Early onset COPD

COPD_EARLY

chronic obstructive pulmonary disease: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE<65 Registry filters: Hospital discharge: ICD-10 — J44 Hospital discharge: ICD-9 — 4912 Hospital discharge: ICD-8 — 49104 Cause of death: ICD-10 — J44 Cause of death: ICD-9 — 4912 Cause of death: ICD-8 — 49104 2 out of 7 registries used, show all original rules.	11359
4. Check minimum number of events None	11359
5. Include endpoints None	11359
6. Filter based on genotype QC (FinnGen only)	10022

Control definitions (FinnGen only)

Control exclude: COPD_EARLYANDLATER

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Alii morbi obstructivi chronici pulmonum

NAME	COPD_EARLY
CONTROL_EXCLUDE	COPD_EARLYANDLATER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE<65
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J44
HD_ICD_9	4912
HD_ICD_8	49104
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J44
COD_ICD_9	4912
COD_ICD_8	49104
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Early onset COPD based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Early onset COPD, excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	81002	25780	53894
Only index persons	60251	21696	38555
Unadjusted period prevalence (%)
Whole population	1.26	0.74	1.51
Only index persons	1.23	0.80	1.47
Median age at first event (years)
Whole population	57.10	56.55	57.32
Only index persons	56.50	56.17	56.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10022	3799	6223
Unadjusted period prevalence (%)	2.28	1.35	2.85
Median age at first event (years)	57.37	56.13	58.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10326: Matched controls
103260

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

321.5

307

R06.2

ICD-10 Finland

Wheezing

4.6

319.1

800

1847

R03AK08

ATC

formoterol and beclometasone; inhalant

4.5

318.7

823

1945

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.6

316.4

328

290

XG466

NOMESCO Finland

Sleep oxymetry

5.2

311.6

665

1341

R04.2

ICD-10 Finland

Haemoptysis

4.8

309.5

733

1615

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.2

308.4

866

2182

N05CD07

ATC

temazepam; oral

3.0

307.7

1724

6553

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

25.0

307.7

1714

816

R03BA01

ATC

beclometasone; inhalant

4.2

307.7

2569

7507

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.7

307.7

729

615

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.5

307.7

1383

2392

R03AK03

ATC

[U] fenoterol and ipratropium bromide

16.9

307.7

2110

1544

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

22.8

307.7

565

261

R95

ICPC

Chron obstructive pulmonary disease

55.2

307.7

2043

459

J01AA02

ATC

doxycycline; systemic

3.0

307.7

8795

67665

J01MA14

ATC

moxifloxacin; systemic

4.2

307.7

1779

4853

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.7

307.7

1345

4024

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

20.2

307.7

318

162

R03DA04

ATC

theophylline; systemic, rectal

16.3

307.7

2026

1525

R03BB01

ATC

ipratropium bromide; inhalant

14.3

307.7

1393

1111

J96.1

ICD-10 Finland

Chronic respiratory failure

28.4

307.7

1077

421

N05BA01

ATC

diazepam; systemic, rectal

2.9

307.7

1877

7386

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

45.7

307.7

1302

325

J01MA12

ATC

levofloxacin; systemic

2.7

307.7

2779

12553

R02

ICPC

Shortness of breath/dyspnoea

4.2

307.7

2584

7553

H02AB04

ATC

methylprednisolone; systemic

3.0

307.7

2146

8345

H02AB07

ATC

prednisone; oral

3.8

307.7

2435

7665

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

307.7

1473

5095

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

13.3

307.7

1215

1024

N05AA02

ATC

levomepromazine; systemic

4.9

307.7

822

1805

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

307.7

538

C03CA01

ATC

furosemide; systemic

3.2

307.7

4605

20977

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

548.5

307.7

8661

970

R03AC03

ATC

terbutaline; inhalant

3.8

307.7

2286

7160

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

6.6

307.7

666

1073

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

307.7

603

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

29.3

307.7

911

340

XG410

NOMESCO Finland

Flow-volume spirometry

6.6

307.7

954

1560

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

64.9

307.7

247

R03AC18

ATC

indacaterol; inhalant

45.6

307.7

370

J01FA06

ATC

roxithromycin; oral

2.4

307.7

4859

28127

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.9

307.7

1123

2513

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.0

307.7

1984

3942

N07BA03

ATC

varenicline; oral

7.2

307.7

1307

2051

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.0

307.7

4204

6652

J45.9

ICD-10 Finland

Asthma, unspecified

7.3

307.7

4658

10486

R03BB04

ATC

tiotropium bromide; inhalant

37.2

307.7

5626

3221

J45.1

ICD-10 Finland

Nonallergic asthma

7.4

307.7

1940

3146

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

307.7

6004

39615

H02AB06

ATC

prednisolone; systemic

5.7

307.7

7760

35789

Z72.0

ICD-10 Finland

Tobacco use

8.1

307.7

732

959

R03AC12

ATC

salmeterol; inhalant

10.9

307.7

1391

1453

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

20.3

307.7

407

208

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.0

307.7

1657

3783

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

44.0

307.7

410

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

188.6

307.7

3533

284

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.2

307.7

1999

4596

R03BA05

ATC

fluticasone; inhalant

4.2

307.7

3141

9809

GD1AD

NOMESCO Finland

Thorax CT examination

3.9

307.7

1260

3590

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

37.4

307.7

1082

322

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

5.2

307.7

2421

5764

J46

ICD-10 Finland

Status asthmaticus

9.2

307.7

784

913

J45

ICD-10 Finland

Asthma

4.0

307.7

1791

5204

R03AC13

ATC

formoterol; inhalant

7.7

307.7

1301

1900

R03BB07

ATC

umeclidinium bromide; inhalant

16.5

307.7

289

180

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

271.2

307.7

2631

130

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

2607

12164

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

307.7

1006

2387

R03AK07

ATC

formoterol and budesonide; inhalant

4.2

307.7

3778

12549

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

13.3

307.7

6055

9946

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

6505

39111

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

307.7

1376

3791

J45.8

ICD-10 Finland

Mixed asthma

9.2

307.7

867

1021

R06.0

ICD-10 Finland

Dyspnoea

3.7

307.7

4547

17931

J43.9

ICD-10 Finland

Emphysema, unspecified

24.4

307.7

732

322

R03BA02

ATC

budesonide; inhalant

4.0

307.7

3076

9923

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

234.9

307.7

3862

262

R96

ICPC

Asthma

4.5

307.7

1954

5090

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

41.6

307.7

400

100

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

307.7

2099

8040

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.5

307.7

4955

17562

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

13.8

307.7

374

281

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

307.7

2951

11797

R03DC03

ATC

montelukast; oral

3.3

307.7

2472

9079

R03AC02

ATC

salbutamol; inhalant

8.3

307.7

8622

38965

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

307.7

1709

6097

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.6

307.7

3225

11632

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.3

307.7

787

1571

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

291.0

1104

3424

348

Kela drug reimbursment

Roflumilast

+∞

289.9

277

N06AB04

ATC

citalopram; systemic

2.4

286.8

2584

12667

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.4

284.7

583

1132

R03BB02

ATC

oxitropium bromide; inhalant

20.0

275.6

212

108

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.3

273.3

569

1121

J96.0

ICD-10 Finland

Acute respiratory failure

9.1

266.7

331

376

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.6

264.6

381

518

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.2

262.1

557

1117

R03DX07

ATC

roflumilast; oral

+∞

259.4

248

N05AH04

ATC

quetiapine; oral

2.4

256.0

2113

9905

N07BB01

ATC

disulfiram; oral

3.9

251.4

792

2162

SPAT1059

SPAT

Spirometry at the office

3.8

248.8

813

2276

N05CF01

ATC

zopiclone; oral

2.1

248.3

3773

22565

I50.0

ICD-10 Finland

Congestive heart failure

3.2

247.2

1095

3722

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.0

243.9

541

1125

P17

ICPC

Tobacco abuse

7.9

243.2

338

441

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

242.4

2075

9862

R03AC19

ATC

olodaterol

28.7

240.6

161

N02AX02

ATC

tramadol; systemic, rectal

2.0

238.9

5161

34782

N05BA04

ATC

oxazepam; oral

2.1

232.5

2979

16647

R03BB06

ATC

glycopyrronium bromide; inhalant

26.7

225.9

155

J20

ICD-10 Finland

Acute bronchitis

2.7

224.6

1385

5625

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.8

219.9

703

1935

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

219.4

1454

6116

A06AD11

ATC

lactulose; oral

2.3

216.4

1893

9038

Z2446

NOMESCO Finland

Social worker

3.3

215.2

871

2796

J42

ICD-10 Finland

Unspecified chronic bronchitis

8.1

213.1

289

366

SPAT1254

SPAT

Administration of medicine

2.4

212.8

1757

8175

C07AB07

ATC

bisoprolol; oral

1.9

212.1

5646

40175

N05AF03

ATC

chlorprothixene; systemic

4.9

211.2

475

998

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.3

206.8

424

822

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.6

200.1

390

722

R03AK11

ATC

formoterol and fluticasone; inhalant

5.0

199.4

436

894

J47

ICD-10 Finland

Bronchiectasis

6.0

197.4

358

619

K05.31

ICD-10 Finland

Periodontitis pronounced

2.4

196.0

1614

7480

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.5

192.3

279

382

A07AA02

ATC

nystatin; oral

3.2

192.0

812

2672

J01FF01

ATC

clindamycin; systemic

1.9

191.4

3166

19136

N05AH03

ATC

olanzapine; systemic

3.1

189.0

834

2814

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.0

188.5

2767

16041

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.4

188.3

706

2156

A01AB09

ATC

miconazole; local oral

2.8

185.2

1044

4031

WX892

NOMESCO Finland

Monitored bed care

2.7

184.8

1096

4344

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.3

184.5

377

728

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

36.8

182.1

113

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

9.2

181.8

221

244

XG405

NOMESCO Finland

Education on PEF monitoring

6.4

181.6

303

482

R03BA08

ATC

ciclesonide; inhalant

2.7

181.1

1112

4483

C03DA01

ATC

spironolactone; oral

2.3

179.3

1589

7579

N05BA02

ATC

chlordiazepoxide; systemic

4.5

178.2

450

1038

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

173.6

376

764

J01DA01

ATC

[U] cefalexin

1.8

173.0

6401

49035

G47.3

ICD-10 Finland

Sleep apnoea

1.9

172.7

3018

18459

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.5

170.3

433

1004

P15

ICPC

Chronic alcohol abuse

3.9

169.8

527

1417

N06AX11

ATC

mirtazapine; oral

1.8

168.0

3622

23615

R05CB01

ATC

acetylcysteine; inhalant, oral

6.4

166.2

277

440

WX722

NOMESCO Finland

PEEP

3.1

164.7

743

2534

J43.8

ICD-10 Finland

Other emphysema

21.6

164.3

122

XG460

NOMESCO Finland

Short time oxymetry

6.1

163.9

287

479

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

163.6

3336

21346

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

159.6

1585

7892

N03AG01

ATC

valproic acid; systemic, rectal

2.9

158.7

791

2852

A46

ICD-10 Finland

Erysipelas

2.1

158.3

1900

10170

N02AA05

ATC

oxycodone; systemic

2.0

156.7

2215

12560

EBA00

NOMESCO Finland

Extraction of tooth

1.8

156.2

3932

26692

F10.24

ICD-10 Finland

Alcohol depence active use

5.3

154.6

316

610

R28

ICPC

Limited function/disability (R)

6.1

153.6

269

449

V03AA01, ,

ATC

4.9

153.1

344

721

N06AB03

ATC

fluoxetine; oral

2.3

152.7

1376

6579

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

150.7

2586

15608

C01AA05

ATC

digoxin; systemic

2.6

150.0

964

3959

N03AX16

ATC

[U] pregabalin

1.9

149.5

2589

15666

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

9.4

147.2

176

190

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

146.9

825

3166

R03BB05

ATC

aclidinium bromide; inhalant

24.8

146.3

103

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

146.2

1478

7393

A02BC02

ATC

pantoprazole; systemic

1.8

145.9

7256

59005

TGC00

NOMESCO Finland

Bronchial lavation

3.9

145.3

436

1143

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

145.3

795

3010

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.8

145.1

333

710

R81

ICPC

Pneumonia

3.3

143.6

563

1763

N05AH02

ATC

clozapine; systemic

5.4

143.4

286

540

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

142.3

866

3460

A02BC01

ATC

omeprazole; systemic

1.8

141.9

2920

18578

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

5.5

141.8

277

513

N06AX16

ATC

venlafaxine; oral

2.1

141.8

1494

7588

J43.2

ICD-10 Finland

Centrilobular emphysema

15.6

141.0

122

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.0

139.9

308

634

J43

ICD-10 Finland

Emphysema

37.7

139.4

Z3231

NOMESCO Finland

Registered nurse

1.8

138.9

2940

18840

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

138.7

1508

7747

N05AA01

ATC

chlorpromazine; systemic, rectal

5.8

138.2

256

451

ZXD05

NOMESCO Finland

Urgent procedure

1.8

138.2

3096

20162

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.5

138.2

507

1522

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

137.1

1423

7178

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

136.3

612

2077

Z3226

NOMESCO Finland

Physiotherapist

1.9

135.9

1979

11272

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.8

135.7

252

445

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

134.7

859

3509

N05AB01

ATC

dixyrazine; systemic

5.7

133.7

251

448

J37.0

ICD-10 Finland

Chronic laryngitis

3.5

133.3

487

1458

R05

ICPC

Cough

1.8

132.2

2602

16279

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

131.1

2916

18897

J96.9

ICD-10 Finland

Respiratory failure, unspecified

9.2

131.0

159

175

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.7

130.3

433

1218

N06AX12

ATC

bupropion; oral

2.7

130.2

729

2789

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

129.6

673

2475

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

7.0

129.5

199

290

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.5

129.3

325

746

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

128.9

1041

4733

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

128.2

2060

12091

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.4

127.9

330

773

R60.0

ICD-10 Finland

Localized oedema

2.0

126.9

1486

7828

WX721

NOMESCO Finland

Oxygen concentrator therapy

21.8

125.7

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

8.3

124.1

164

201

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

123.4

1572

8527

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

122.4

471

1456

A28

ICPC

Limited function/disability NOS

1.9

121.4

1922

11206

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.2

121.2

207

337

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.5

120.3

421

1225

N05AB03

ATC

perphenazine; systemic, rectal

3.3

119.2

474

1495

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

119.0

771

3168

A02BA02

ATC

ranitidine; systemic

1.8

118.8

2081

12515

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

6.9

118.2

183

269

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

118.0

716

2849

N04AA02

ATC

biperiden; systemic

4.3

117.9

308

728

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

28.4

117.7

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

117.6

3770

26767

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.5

116.3

229

427

N05AD01

ATC

haloperidol; systemic

3.3

116.0

454

1418

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.3

115.0

441

1360

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

114.6

3118

21195

N06AA12

ATC

doxepin; systemic

2.7

114.5

641

2449

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

114.3

3560

25049

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

16.0

113.8

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.6

113.7

273

604

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

8.2

113.3

151

187

K08.3

ICD-10 Finland

Retained dental root

2.2

113.1

1028

4900

J01FA09

ATC

clarithromycin; systemic

1.7

112.8

3096

21075

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

111.3

2127

13098

A01AB04

ATC

amphotericin B; local oral

2.9

110.4

554

1997

N05AC02

ATC

thioridazine; oral

4.3

109.9

290

691

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.9

109.8

325

843

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.2

109.7

188

307

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.2

109.6

145

178

J98.1

ICD-10 Finland

Pulmonary collapse

8.3

109.2

144

176

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

109.0

3288

22887

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

108.7

1811

10692

P01AB01

ATC

metronidazole; oral, rectal

1.6

108.6

3859

27954

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

108.1

1479

8193

R03DC01

ATC

zafirlukast; oral

4.8

108.1

244

513

A98

ICPC

Health maint/preventive medicine

0.5

107.7

8499

92417

N05AF05

ATC

zuclopenthixol; systemic

6.0

107.2

191

324

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

107.1

1360

7341

SPAT1058

SPAT

PEF monitoring instruction

2.3

107.1

894

4110

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.2

107.0

222

434

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.7

106.6

352

985

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

106.5

1462

8105

C01DA14

ATC

isosorbide mononitrate; oral

1.8

105.2

1722

10100

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

104.8

2762

18540

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.6

104.6

170

263

J01CA04

ATC

amoxicillin; systemic

1.7

103.8

8021

69425

A02BC03

ATC

lansoprazole; oral

1.6

103.8

2953

20203

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

103.8

838

3797

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

103.4

723

3073

M05BA04

ATC

alendronic acid; oral

2.3

103.3

841

3823

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.8

103.1

234

494

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

102.7

2504

16453

N05BE01

ATC

buspirone; oral

3.3

102.5

398

1236

S97

ICPC

Chronic ulcer skin

2.3

102.3

808

3626

A10BA02

ATC

metformin; oral

1.6

102.2

3197

22376

N05AX12

ATC

aripiprazole; systemic

3.3

101.7

404

1273

WX730

NOMESCO Finland

Conventional respirator

4.3

100.8

263

621

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.6

99.5

191

348

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.2

98.6

206

405

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

98.6

1097

5639

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.7

97.8

320

890

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.9

96.8

213

438

N06AX03

ATC

mianserin; oral

2.6

96.3

574

2260

N06AA09

ATC

amitriptyline; systemic

2.1

96.1

1028

5206

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.7

95.0

178

317

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

95.0

2544

17072

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

7.8

94.9

132

172

R4110

NOMESCO Finland

Physiotherapy

1.6

94.7

2886

19994

R06AE07

ATC

cetirizine; oral

1.6

94.7

4035

30207

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

94.6

1492

8625

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

11.0

94.6

101

N05AX08

ATC

risperidone; systemic

2.2

94.3

885

4261

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

22.4

94.2

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

6.6

93.9

151

231

SPAT1263

SPAT

Sampling

1.6

93.9

3931

29298

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.1

93.7

199

397

E66.9

ICD-10 Finland

Obesity, unspecified

3.0

93.7

433

1490

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.4

93.1

236

545

R29

ICPC

Respiratory symptom/complaint other

2.3

93.0

774

3547

J01FA15

ATC

telithromycin; oral

2.0

92.8

1076

5609

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

92.4

736

3310

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

92.4

3170

22563

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

91.9

3014

21221

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

8.4

91.9

120

145

SPE90

NOMESCO Finland

Other partial denture

3.5

91.2

315

908

T90

ICPC

Diabetes non-insulin dependent

1.6

90.6

2794

19373

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

89.1

790

3715

N02AA01

ATC

morphine; systemic, rectal

3.7

88.9

284

777

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

88.7

2596

17758

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

5.3

88.6

178

338

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

88.5

453

1648

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.1

88.2

375

1230

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

3.7

86.8

277

757

XQ800

NOMESCO Finland

Prick test

2.3

86.8

700

3164

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

86.2

804

3856

N06AB06

ATC

sertraline; oral

2.0

85.4

1059

5645

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.8

85.2

156

272

1240

FHL

Bronchoscopy

5.2

85.1

176

343

N06AB10

ATC

escitalopram; oral

1.7

84.9

1803

11339

N03AX12

ATC

[U] gabapentin; oral

1.7

84.4

1657

10193

R78

ICPC

Acute bronchitis/bronchiolitis

3.6

84.4

285

809

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.8

84.4

194

414

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

84.4

551

2265

49300

ICD-8 Finland

Asthma, bronchiale

3.4

84.4

309

925

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.5

84.3

165

306

P72

ICPC

Schizophrenia

3.8

84.3

262

703

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

84.1

453

1693

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

83.5

230

566

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

9.0

83.4

103

116

F61.0

ICD-10 Finland

Mixed personality disorders

4.3

83.2

214

500

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

83.1

2727

19118

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

13.9

82.6

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.1

82.0

352

1161

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

81.8

1652

10235

GDG10

NOMESCO Finland

Bilateral transplantation of lung

22.3

81.8

RS221, ,

NOMESCO Finland

4.5

81.1

202

460

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

80.7

285

833

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

80.2

2723

19210

B01AC04

ATC

clopidogrel; oral

1.7

80.2

1851

11885

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

80.0

2334

15893

N06AX21

ATC

duloxetine; oral

1.9

80.0

1179

6649

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

79.8

4402

34409

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.5

79.7

131

205

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

79.7

801

3952

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

10.1

79.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

79.5

757

3657

R04

ICPC

Breathing problem other

2.6

79.3

484

1925

J01DA09

ATC

[U] cefadroxil

1.6

79.3

2513

17442

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

79.0

592

2589

Z2221

NOMESCO Finland

Medical doctor

1.6

79.0

2537

17662

E66.8

ICD-10 Finland

Other obesity

2.4

78.9

584

2541

P99

ICPC

Psychological disorders other

3.2

78.8

326

1052

SPAT1240

SPAT

Therapeutic discussion

2.0

78.7

869

4439

R79

ICPC

Chronic bronchitis

16.1

78.6

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

7.4

78.6

114

156

J01DA06

ATC

[U] cefuroxime

1.8

78.0

1412

8472

A02BA04

ATC

nizatidine; systemic

2.1

78.0

821

4121

Z51.5

ICD-10 Finland

Palliative care

2.0

77.9

992

5329

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

5.0

77.7

170

348

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.1

77.0

164

328

AA1AD

NOMESCO Finland

CT of head and brain

1.5

76.8

2991

21709

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

76.6

473

1892

SPAT1060

SPAT

Administration of oxygen

9.6

76.2

P29

ICPC

Psychological sympt/compl other

2.3

75.9

616

2788

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.8

75.7

233

621

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

5.5

75.5

146

268

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

75.5

502

2080

N05AN01

ATC

lithium; oral

3.3

75.0

291

903

E87.6

ICD-10 Finland

Hypokalaemia

2.7

74.9

413

1561

Z94.2

ICD-10 Finland

Lung transplant status

13.9

74.9

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

5.0

74.8

162

329

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

74.6

2577

18197

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

6.8

74.4

117

175

I50.1

ICD-10 Finland

Left ventricular failure

2.3

74.3

596

2683

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

74.2

2740

19632

N05BA12

ATC

alprazolam; oral

1.9

73.9

1002

5491

GDC00

NOMESCO Finland

Lobectomy of lung

7.0

73.9

112

161

A01

ICPC

Pain general/multiple sites

1.9

73.6

1033

5726

S10

ICPC

Boil/carbuncle

2.2

73.5

667

3159

A03

ICPC

Fever

1.7

73.2

1513

9408

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

6.1

73.2

127

210

AN1

Coronary angiography

1.8

73.2

1211

7067

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

72.7

1049

5866

GX1K5

NOMESCO Finland

Diffusion capacity

5.9

72.7

131

225

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

6.2

72.5

123

199

OAB43, ,

SPAT

0.5

72.4

904

15886

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.9

72.0

161

336

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

71.9

1246

7369

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

5.5

71.8

140

259

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

9.0

71.3

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.8

71.2

160

335

J01DB01

ATC

cefalexin; oral

1.6

70.5

8191

73347

N03AX09

ATC

lamotrigine; oral

2.5

70.4

457

1872

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

70.1

628

2958

R03DA05

ATC

aminophylline; systemic, rectal

6.4

70.1

116

183

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

8.3

70.0

112

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.1

70.0

149

298

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

70.0

3978

31026

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.9

69.6

206

534

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

69.6

1307

7907

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

69.3

2705

19559

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

69.2

1445

8999

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

7.2

69.2

102

142

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

69.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

69.2

1001

5598

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.5

69.1

135

250

L28

ICPC

Limited function/disability (L)

1.6

69.0

1859

12359

N03AF01

ATC

carbamazepine; oral, rectal

2.3

69.0

561

2540

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

68.9

392

1505

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

5.1

68.8

144

284

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

19.7

68.6

Z72.1

ICD-10 Finland

Alcohol use

4.0

67.6

196

501

S22.3

ICD-10 Finland

Fracture of rib

2.0

67.5

828

4382

B01AA03

ATC

warfarin; systemic

1.6

67.3

1928

12997

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.3

67.1

260

806

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

67.0

1421

8883

P03

ICPC

Feeling depressed

2.0

66.8

773

4008

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

66.6

496

2162

WX882

NOMESCO Finland

High dependency care

2.8

66.4

350

1292

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

66.3

2493

17854

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.0

66.2

117

197

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

65.6

541

2462

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

65.6

611

2922

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

65.6

224

641

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

5.4

65.3

128

238

ZXE00

NOMESCO Finland

One hour or less

1.5

65.2

3557

27425

F34.1

ICD-10 Finland

Dysthymia

2.7

64.9

360

1365

A10AE04

ATC

insulin glargine; parenteral

1.8

64.8

1051

6085

SPAT1262

SPAT

Handing over of treatment supplies

1.6

64.6

1815

12166

L73.2

ICD-10 Finland

Hidradenitis suppurativa

5.3

64.5

130

248

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.9

64.4

189

487

E000001, ,

ATC

1.6

64.4

1764

11754

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

12.4

64.0

R03AC04

ATC

fenoterol; inhalant

7.7

63.5

117

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

63.5

186

479

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

6.3

62.9

105

167

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.6

62.9

151

334

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

62.8

628

3086

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.4

62.4

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.7

62.3

144

309

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

62.3

712

3674

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

61.8

686

3502

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

61.8

794

4265

J98.2

ICD-10 Finland

Interstitial emphysema

22.6

61.6

P16

ICPC

Acute alcohol abuse

3.4

61.5

227

683

E0000UV, ,

ATC

1.4

61.3

3794

29850

P01

ICPC

Feeling anxious/nervous/tense

1.9

61.2

827

4518

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

60.5

1858

12694

P76

ICPC

Depressive disorder

2.2

60.1

556

2651

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

59.9

450

1968

R03CC02

ATC

salbutamol; systemic

2.7

59.3

324

1219

R05CB02

ATC

bromhexine; systemic

3.7

59.2

187

508

J41.0

ICD-10 Finland

Simple chronic bronchitis

5.7

58.9

109

192

SPD00

NOMESCO Finland

Mucosa borne complete denture

4.2

58.8

159

386

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

10.1

58.3

WX872

NOMESCO Finland

Intensive care

2.1

58.0

613

3074

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.6

57.9

195

553

130

Kela drug reimbursment

Malignant tumour

1.8

57.8

1005

5929

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.9

57.7

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

4.1

57.5

161

401

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

6.1

57.5

100

166

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

57.5

2602

34038

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.6

57.4

335

1303

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

4.9

57.3

127

263

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.4

57.3

147

M54.5

ICD-10 Finland

Low back pain

1.4

56.9

3348

26011

A10AB05

ATC

insulin aspart; parenteral

1.9

56.8

802

4439

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

56.7

470

2143

ZX120

NOMESCO Finland

Intravenous

1.8

56.7

925

5355

SPAT1057

SPAT

Peak expiratory flow measurement

3.0

56.5

248

828

J86.9

ICD-10 Finland

Pyothorax without fistula

4.4

56.5

140

318

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.5

56.4

381

1588

J01FA10

ATC

azithromycin; systemic

1.4

56.3

5058

42212

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.2

56.0

115

223

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.4

56.0

110

205

J43.1

ICD-10 Finland

Panlobular emphysema

89.2

55.9

A08

ICPC

Swelling

2.1

55.7

581

2897

SPAT1255

SPAT

Intravenous administration of medicine

1.9

55.6

701

3739

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

55.5

1082

6588

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

55.5

252

858

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

55.5

692

3677

RK320, ,

NOMESCO Finland

4.7

55.3

127

271

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

13.4

55.3

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

55.0

3591

28367

WW200

NOMESCO Finland

Immunization

2.6

54.9

316

1220

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.6

54.6

132

N05AD03

ATC

melperone; systemic

3.8

54.5

169

453

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

54.4

4053

32724

A04

ICPC

Weakness/tiredness general

1.6

54.4

1349

8743

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

54.4

454

2076

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

54.3

500

2377

A02BC05

ATC

esomeprazole; systemic

1.4

54.0

3874

31071

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

3.2

53.8

219

700

C08DA01

ATC

verapamil; systemic

2.3

53.6

413

1826

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.8

53.5

122

259

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

53.3

723

3948

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

53.0

1627

11081

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

52.9

328

1313

30041

ICD-8 Finland

Neuroses, Depressiva

3.7

52.9

168

458

N06AA06

ATC

trimipramine; systemic

2.8

52.8

264

948

GX2C5

NOMESCO Finland

Short-lasting oximetry

5.4

52.7

103

191

N05AF01

ATC

flupentixol; systemic

3.5

52.7

187

549

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

52.6

468

2196

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.7

52.5

122

263

RS220, ,

NOMESCO Finland

3.9

52.5

156

406

W19

ICD-10 Finland

Unspecified fall

1.7

52.5

959

5731

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

52.2

1142

7165

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

52.1

461

2157

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

52.1

1872

13185

N06AB05

ATC

paroxetine; oral

2.0

52.1

559

2816

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

52.1

436

1995

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

52.1

490

2350

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

52.0

974

5860

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

52.0

918

5433

R05CB03

ATC

carbocisteine; oral

3.0

51.9

231

778

N03AE01

ATC

clonazepam; systemic

2.0

51.7

570

2900

C08DB01

ATC

diltiazem; oral

2.1

51.7

501

2430

PD3AT

NOMESCO Finland

Pelvic artery PTA

5.5

51.5

181

R74

ICPC

Upper respiratory infection acute

1.4

51.3

2555

19180

30180

ICD-8 Finland

Personality disorders, Immatura

5.7

51.3

171

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

9.6

51.2

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

5.5

51.2

182

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

51.1

468

2220

ZY010

NOMESCO Finland

Hospital outpatient

2.2

50.9

438

2027

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

50.7

351

1480

R50.9

ICD-10 Finland

Fever, unspecified

1.6

50.7

1443

9652

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.3

50.7

133

316

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.2

50.6

202

638

R11

ICD-10 Finland

Nausea and vomiting

1.8

50.6

752

4226

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.4

50.6

184

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.2

50.4

446

2087

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.5

50.4

181

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.0

50.2

142

357

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

14.0

50.1

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

5.0

50.1

107

215

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

49.8

1103

6938

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

8.0

49.8

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.1

49.8

211

691

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.7

49.7

116

251

OAA67, ,

SPAT

0.5

49.7

467

9093

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

49.5

548

2791

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

49.4

278

1062

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

49.3

1296

8503

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

49.3

379

1673

N05CD02

ATC

nitrazepam; oral

3.3

49.2

191

593

M04AA01

ATC

allopurinol; systemic

1.6

49.2

1414

9475

C09AA05

ATC

ramipril; oral

1.4

49.1

2513

18935

SPAT1301

SPAT

No procedures

1.4

49.0

2774

21280

N05BB01

ATC

hydroxyzine; systemic

2.0

48.7

542

2765

SPD01

NOMESCO Finland

Mucosa-supported complete denture

3.8

48.7

149

396

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

48.6

262

979

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

48.6

309

1253

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

9.7

48.3

JN4AD

NOMESCO Finland

Body CT examination

1.6

48.3

1253

8195

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

5.0

48.2

103

207

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.0

48.2

105

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.4

48.1

119

270

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

48.0

796

4621

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.9

48.0

147

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

4.8

48.0

107

223

A02BA03

ATC

famotidine; systemic

2.3

47.8

384

1727

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

8.2

47.8

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

47.8

1987

14384

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.0

47.6

135

340

SPAT1234

SPAT

Support of social functional capacity

2.1

47.6

480

2363

F20.5

ICD-10 Finland

Residual schizophrenia

5.3

47.4

184

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.8

47.4

144

381

R03CC03

ATC

terbutaline; systemic

3.7

47.4

151

413

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

47.3

272

1050

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.7

47.3

156

RK110, ,

NOMESCO Finland

5.0

47.3

101

203

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.3

47.2

181

JN4BD

NOMESCO Finland

Extensive body CT

1.7

47.2

1036

6496

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.4

47.2

174

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.2

47.1

189

599

SPE01

NOMESCO Finland

Mucosa-supported partial denture

2.7

46.9

265

1014

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

46.8

897

5427

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

7.5

46.6

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.9

46.4

102

210

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.4

46.4

168

500

K92.0

ICD-10 Finland

Haematemesis

2.6

46.3

276

1085

L57.0

ICD-10 Finland

Actinic keratosis

0.4

46.1

328

7063

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

46.0

665

3704

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

45.8

206

698

T74.1

ICD-10 Finland

Physical abuse

3.3

45.7

172

524

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.2

45.7

123

298

R84

ICPC

Malignant neoplasm bronchus/lung

6.1

45.5

131

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

45.4

1274

8477

SPA47

NOMESCO Finland

Precision impression for denture

2.4

45.3

323

1380

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

45.2

672

3773

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

45.2

866

13742

Z08

ICPC

Social welfare problem

3.5

45.1

158

460

SPAT1265

SPAT

Breathalyser

4.0

45.1

126

314

I50

ICD-10 Finland

Heart failure

2.5

44.9

297

1227

K07

ICPC

Swollen ankles/oedema

2.1

44.7

464

2308

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

44.6

246

930

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

44.6

198

666

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.2

44.6

180

573

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

44.6

1172

7680

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.5

44.5

158

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

44.4

3449

27775

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

12.3

44.4

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.5

44.4

107

238

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.6

44.4

262

1025

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

5.7

44.1

142

A12BA01

ATC

potassium chloride; oral

2.2

44.1

374

1721

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

44.0

1297

8722

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

43.9

537

2831

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

9.7

43.8

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

43.7

595

3250

J01FA01

ATC

erythromycin; systemic

1.6

43.7

1045

6691

E000003, ,

ATC

2.2

43.6

397

1879

E86

ICD-10 Finland

Volume depletion

2.5

43.5

272

1094

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

16.1

43.5

SPAT1104

SPAT

Monitoring of emergency patient

1.9

43.5

614

3393

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.5

43.5

106

238

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.2

43.4

114

271

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

43.1

636

3562

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

43.1

447

2223

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.4

43.0

107

244

R51.80

ICD-10 Finland

Headache

1.6

43.0

1252

8395

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

42.9

559

3010

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

42.8

602

3323

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

42.7

388

1834

N06AB08

ATC

fluvoxamine; oral

2.5

42.7

276

1128

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

42.6

1462

10157

XG420

NOMESCO Finland

Time-volume spirometry

12.9

42.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

42.5

618

3446

GX1E5, ,

SPAT

3.2

42.4

172

549

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.6

42.4

141

397

N06AA10

ATC

nortriptyline; systemic

2.8

42.4

218

795

N02AC04

ATC

dextropropoxyphene; oral

2.2

42.4

368

1709

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

42.4

285

1186

RS230, ,

NOMESCO Finland

5.6

42.3

144

R53

ICD-10 Finland

Malaise and fatigue

1.4

42.3

2118

15830

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.1

42.3

173

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.8

42.2

129

343

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

42.0

671

3851

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

6.6

42.0

102

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.9

41.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

41.8

3439

27875

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

12.9

41.7

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

41.6

1130

7454

ZY000

NOMESCO Finland

Hospital inpatient

3.9

41.6

122

315

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

41.5

1827

24393

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

41.5

237

912

S76

ICPC

Skin infection other

1.9

41.5

547

2956

WX002

NOMESCO Finland

Sedation and analgesia

1.5

41.3

1768

12829

EB4VA, ,

NOMESCO Finland

0.6

41.3

636

10704

A01AB10

ATC

natamycin; local oral

2.5

41.2

258

1038

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

41.2

1917

14128

P74

ICPC

Anxiety disorder/anxiety state

2.3

41.2

319

1413

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.8

41.2

205

735

-50

ICPC

Medication/prescr/renewal

2.1

41.1

389

1869

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

40.9

1642

11765

DQA10

NOMESCO Finland

Biopsy of larynx

4.6

40.9

209

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

9.3

40.9

SPAT1260

SPAT

Consultation of another employee

1.5

40.9

1535

10856

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

40.9

428

2136

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.0

40.8

179

598

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

15.0

40.8

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

6.6

40.7

RK250, ,

NOMESCO Finland

5.2

40.7

164

PE1AT

NOMESCO Finland

Femoral artery PTA

3.4

40.7

149

447

4289X

ICD-9 Finland

Heart failure, unspecified

6.7

40.6

J01DA08

ATC

[U] cefaclor

1.7

40.6

756

4531

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

40.3

821

5040

N05AA03

ATC

promazine; systemic

9.6

40.3

R24

ICPC

Haemoptysis

4.5

40.2

216

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

4.6

40.2

212

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.4

40.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

40.2

989

6371

UJF32

NOMESCO Finland

Coloscopy

1.4

40.1

2520

19554

RS222, ,

NOMESCO Finland

3.6

40.0

131

365

J01MA02

ATC

ciprofloxacin; systemic

1.3

40.0

3748

30915

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

40.0

4038

33671

GX1C5, ,

SPAT

3.9

39.9

119

311

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.4

39.8

272

1140

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.0

39.8

113

285

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

39.8

359

1693

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

5.7

39.7

128

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

39.5

3229

26089

J02AC01

ATC

fluconazole; systemic

1.4

39.5

2981

23797

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

39.2

192

683

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

13.3

39.1

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.3

38.7

305

1361

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

38.7

666

3903

D07AA02

ATC

hydrocortisone; topical

1.6

38.6

1116

7459

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

38.4

366

1763

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

38.3

431

2207

N02BF02

ATC

pregabalin; oral

1.8

38.3

644

3750

K29.2

ICD-10 Finland

Alcoholic gastritis

6.5

38.2

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.1

38.2

109

R01

ICPC

Pain respiratory system

3.0

38.2

172

584

I20.09

ICD-10 Finland

Unstable angina

1.8

38.1

578

3263

B37.08

ICD-10 Finland

Other candidal stomatitis

3.8

38.1

114

299

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

38.0

372

1811

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

37.9

141

427

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.8

37.9

591

3365

GX1D5

NOMESCO Finland

Flow volume spirometry

6.4

37.8

T82

ICPC

Obesity

2.1

37.8

368

1787

F32

ICD-10 Finland

Depressive episode

2.0

37.7

401

2012

N06AX05

ATC

trazodone; oral

2.5

37.5

233

935

A10AC01

ATC

insulin (human); parenteral

1.7

37.4

676

4017

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

37.3

305

1383

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.2

37.2

238

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

37.1

724

4392

XF402

NOMESCO Finland

ECG with work load test

1.6

37.0

1027

6799

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

37.0

1632

11885

UJD02

NOMESCO Finland

Gastroscopy

1.9

37.0

461

2445

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

37.0

217

847

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

36.9

563

3183

L30.3

ICD-10 Finland

Infective dermatitis

2.1

36.9

350

1683

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

6.6

36.9

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.8

36.7

111

293

D07AC01

ATC

betamethasone; topical

1.3

36.7

3374

27665

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

36.6

2628

20775

R52.0

ICD-10 Finland

Acute pain

2.2

36.5

299

1356

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

36.5

357

1737

R03

ICPC

Wheezing

3.4

36.4

131

389

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

36.3

325

1528

N05AL01

ATC

sulpiride; systemic

3.0

36.2

158

527

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

7.9

36.2

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.2

36.0

141

441

C10AA01

ATC

simvastatin; oral

1.3

35.9

4073

34351

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.5

35.9

222

889

K85

ICD-10 Finland

Acute pancreatitis

2.8

35.9

186

682

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

35.8

348

1690

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

12.5

35.7

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

7.8

35.7

P28

ICPC

Limited function/disability (P)

4.2

35.6

229

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

35.6

1571

11435

SBA00

NOMESCO Finland

Microbiological examinations

2.4

35.5

252

1075

K59.0

ICD-10 Finland

Constipation

1.8

35.5

515

2868

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.4

35.5

125

366

L17

ICPC

Foot/toe symptom/complaint

1.3

35.4

2761

22077

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

3.7

35.3

112

306

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.3

35.3

132

R07.3

ICD-10 Finland

Other chest pain

1.6

35.2

958

6311

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.1

35.2

340

1647

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

34.9

3331

27409

SPF30

NOMESCO Finland

Relining of denture

2.7

34.8

183

676

M79.6

ICD-10 Finland

Pain in limb

1.3

34.8

3932

33102

R52.2

ICD-10 Finland

Other chronic pain

2.1

34.7

347

1702

TGD00

NOMESCO Finland

Needle biopsy of lung

4.8

34.7

164

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.4

34.6

127

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

34.6

260

1137

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

34.6

6115

54551

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.4

34.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

34.5

227

936

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

9.4

34.4

B37.0

ICD-10 Finland

Candidal stomatitis

3.4

34.3

124

369

J93.9

ICD-10 Finland

Pneumothorax, unspecified

5.1

34.3

139

F61

ICD-10 Finland

Mixed and other personality disorders

5.5

34.3

121

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

34.3

409

2137

D11

ICPC

Diarrhoea

1.6

34.2

918

6027

F1246, ,

NOMESCO Finland

9.6

34.1

F20

ICD-10 Finland

Schizophrenia

4.4

34.0

195

V03AB30, ,

ATC

3.7

33.9

107

291

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

33.9

243

1041

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

33.9

433

2315

X57

ICD-10 Finland

Unspecified privation

2.4

33.9

229

956

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

4.4

33.7

192

R10.0

ICD-10 Finland

Acute abdomen

2.2

33.7

302

1420

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

3.2

33.7

132

413

N06AG02

ATC

moclobemide; oral

2.0

33.7

399

2079

RS224, ,

NOMESCO Finland

6.0

33.6

SPAT1229

SPAT

Assessment of need for aid

1.7

33.6

659

4001

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.6

33.6

198

775

SPAT1284

SPAT

Extensive health certificate

2.4

33.5

243

1047

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

33.4

2383

18774

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.6

33.3

170

SPAT1251

SPAT

Organisation of medication

2.2

33.3

298

1402

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

12.3

33.2

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.1

33.2

140

458

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

33.2

303

1436

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

5.9

33.0

101

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

32.9

201

800

SPAT1310

SPAT

Counselling related to known health issue

1.3

32.9

2646

21211

IHZ05, ,

SPAT

2.2

32.8

277

1272

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.4

32.8

119

355

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

32.8

777

4950

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

32.8

661

4043

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

32.7

812

5232

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.3

32.6

123

R01AD09

ATC

mometasone; nasal

1.3

32.6

3834

32357

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

32.6

171

631

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

32.6

364

1859

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

5.1

32.4

131

PD4AD

NOMESCO Finland

CT of lower extremity arteries

3.3

32.4

122

373

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

32.2

331

1640

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

7.7

32.2

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

32.2

164

596

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

6.8

32.2

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

8.3

32.1

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

6.3

32.0

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.9

32.0

151

527

V03AA02, ,

ATC

8.0

31.9

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.8

31.9

152

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

31.9

220

927

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

31.8

1888

14433

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

6.1

31.8

J93.8

ICD-10 Finland

Other pneumothorax

4.9

31.8

141

49099

ICD-8 Finland

Bronchitis, unspecified

3.2

31.7

127

403

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.9

31.7

245

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

31.7

4069

34693

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

31.6

1102

7648

L03

ICPC

Low back symptom/complaint

1.3

31.6

2462

19619

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.3

31.6

117

354

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

31.5

222

944

R13

ICD-10 Finland

Dysphagia

1.7

31.5

660

4078

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.8

31.4

A10BB12

ATC

glimepiride; oral

1.7

31.3

635

3889

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

31.3

6603

59838

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

31.2

556

3288

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

9.1

31.2

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

9.1

31.2

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.8

31.0

249

P18

ICPC

Medication abuse

4.5

30.9

168

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

30.9

1163

8196

N02BF01

ATC

gabapentin; oral

1.5

30.9

948

6407

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.5

30.8

105

301

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.1

30.8

206

P19

ICPC

Drug abuse

4.3

30.8

181

GX2D5

NOMESCO Finland

Sleep oximetry

3.9

30.8

237

R39

ICPC

Respiratory, Physical function test

4.4

30.7

177

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

5.7

30.7

101

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.1

30.7

301

1466

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

30.7

402

2167

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.6

30.7

102

288

M48.0

ICD-10 Finland

Spinal stenosis

1.5

30.6

1148

8084

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.8

30.6

151

540

F31

ICD-10 Finland

Bipolar affective disorder

3.3

30.5

117

362

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

30.4

560

3341

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

30.4

1126

7910

-69

ICPC

Other reason for encounter NEC

2.0

30.4

321

1608

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

30.3

463

2618

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

9.1

30.3

29999

ICD-8 Finland

Unspecified psychosis

5.0

30.2

128

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

30.2

173

668

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

30.2

153

555

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

8.7

30.1

GBB00

NOMESCO Finland

Tracheostomy

2.9

30.1

138

474

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

6.1

30.1

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.9

30.0

228

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

29.9

215

923

C07AA05

ATC

propranolol; systemic

1.4

29.9

1576

11802

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.8

29.9

242

N05CF02

ATC

zolpidem; oral

1.4

29.8

1432

10554

A10BH01

ATC

sitagliptin; oral

1.5

29.7

927

6286

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

29.7

298

1465

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

6.1

29.6

F60.2

ICD-10 Finland

Dissocial personality disorder

6.9

29.6

L01CA04

ATC

vinorelbine; systemic

3.5

29.6

102

295

N06AA04

ATC

clomipramine; systemic

2.6

29.6

165

629

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

5.8

29.5

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

29.5

403

2202

J01CF05

ATC

flucloxacillin; systemic

1.7

29.5

626

3880

SAA04

NOMESCO Finland

Special examination of mouth

1.8

29.4

432

2414

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

29.4

510

2993

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

29.4

230

1025

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.5

29.3

102

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

29.3

403

2206

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

29.2

167

644

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

29.2

2093

16450

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

10.0

29.1

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.2

29.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

29.1

629

3915

F41.00

ICD-10 Finland

Moderate panic disorder

3.0

29.1

126

419

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

29.1

1106

15316

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

8.0

29.0

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.4

28.9

105

314

30188

ICD-8 Finland

Personality disorders, Alia definita

4.6

28.8

145

ECB00

NOMESCO Finland

Suture of gingiva

1.9

28.8

354

1868

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

28.7

420

2345

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

28.7

396

2171

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

6.3

28.6

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

28.6

1959

15283

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

28.6

183

746

SPAT1227

SPAT

Substance abuse rehabilitation

4.0

28.5

205

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

28.5

315

1604

SPAT1281

SPAT

Other administrative function

1.6

28.4

630

3948

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.2

28.3

241

1111

A02BX02

ATC

sucralfate; oral

1.9

28.3

350

1851

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

28.3

192

804

29599

ICD-8 Finland

Schizophrenia, Unspecified type

4.3

28.3

172

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

5.9

28.2

51899

ICD-8 Finland

Bronchiectasis

7.9

28.1

J38.3

ICD-10 Finland

Other diseases of vocal cords

3.0

28.1

123

412

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

28.0

405

2252

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

6.5

28.0

IGY02, ,

SPAT

2.8

28.0

137

488

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

28.0

190

796

SPAT1216

SPAT

Assessment of functional ability

1.4

28.0

1273

9286

ZX108

NOMESCO Finland

Inhalation

3.6

27.9

263

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.5

27.9

153

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

5.0

27.9

118

D07AB08

ATC

desonide; topical

1.5

27.9

880

5978

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

27.9

130

451

TK800

NOMESCO Finland

Hemodialysis

2.2

27.9

231

1054

M05BA07

ATC

risedronic acid; oral

2.3

27.8

207

903

A10BJ02

ATC

liraglutide; parenteral

2.0

27.7

285

1413

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.2

27.7

241

1121

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

27.7

152

575

IHZ04, ,

SPAT

2.8

27.6

142

519

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

27.5

140

509

WZC30

NOMESCO Finland

Teaching

1.4

27.5

1556

11774

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

8.6

27.5

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

4.5

27.5

151

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

27.4

265

1284

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

27.4

413

2326

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

5.0

27.4

116

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

27.4

388

2144

G44.2

ICD-10 Finland

Tension-type headache

1.5

27.4

1028

7231

Y3409

ICD-8 Finland

Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis

10.0

27.4

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

27.2

189

800

F2682, ,

NOMESCO Finland

8.7

27.1

S06.0

ICD-10 Finland

Concussion

1.5

27.0

872

5952

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

26.9

449

2606

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

26.9

1300

9578

ZXA00

NOMESCO Finland

Right side

1.3

26.8

2288

18404

SPAT1252

SPAT

Overall medication plan or its review

1.6

26.8

582

3627

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

26.8

315

1639

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

26.7

311

1612

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

4.0

26.7

184

R06.4

ICD-10 Finland

Hyperventilation

2.8

26.7

136

495

L84

ICD-10 Finland

Corns and callosities

1.9

26.7

319

1669

R4190

NOMESCO Finland

Nutritional therapy

1.9

26.6

346

1861

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

6.3

26.5

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

26.5

472

2792

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

26.4

828

5616

SPAT1211

SPAT

Application of soft bandage

1.6

26.4

704

4609

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

26.3

895

6173

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

26.1

219

1004

N61

ICD-10 Finland

Inflammatory disorders of breast

2.8

26.1

135

495

A10AE05

ATC

insulin detemir; parenteral

1.7

26.1

464

2741

C08CA01

ATC

amlodipine; oral

1.3

26.0

3704

31745

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.3

26.0

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

26.0

678

4416

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

5.5

25.9

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

4.3

25.9

154

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

25.9

209

944

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.8

25.9

1820

22900

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

25.9

630

4037

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

25.9

608

3863

A10BJ06

ATC

semaglutide; parenteral

1.7

25.8

526

3223

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

25.8

572

3581

ZXD35

NOMESCO Finland

Usual procedure

2.0

25.8

293

1506

SPAT1283

SPAT

Restricted health certificate

1.5

25.7

1004

7112

OAB48, ,

SPAT

0.6

25.6

515

8164

R33

ICD-10 Finland

Retention of urine

1.5

25.6

806

5469

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.7

25.6

505

3069

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

25.5

429

2495

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

7.8

25.5

ZXA05

NOMESCO Finland

Left side

1.3

25.4

2101

16804

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

7.1

25.4

P73

ICPC

Affective psychosis

4.7

25.4

124

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.5

25.4

136

P80

ICPC

Personality disorder

5.3

25.3

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

25.3

290

1495

SPAT1360

SPAT

Extensive global examination

1.6

25.3

568

3567

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

25.3

211

966

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.0

25.3

174

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

2.0

25.2

296

1539

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

25.2

1946

15416

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

5.9

25.2

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.6

25.2

224

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

25.2

262

1306

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.0

25.2

179

K92.1

ICD-10 Finland

Melaena

1.7

25.2

496

3014

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

25.0

272

1377

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

9.7

25.0

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

7.1

25.0

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.4

25.0

175

744

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

25.0

1717

21692

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

24.9

227

1077

B01AB05

ATC

enoxaparin; parenteral

1.3

24.8

2800

23315

SPAT1097

SPAT

Recording of ECG

1.4

24.7

1252

9289

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

24.7

188

828

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

24.7

600

3841

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.1

24.7

164

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.5

24.7

135

D01

ICPC

Abdominal pain/cramps general

1.5

24.7

928

6526

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023419) Bacteria identified in Sputum by Culture

689

1109

6.59

307.65

3.0

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3474

15498

2.87

307.65

2.8

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1737

5928

3.32

307.65

11.3

10.4

25.24

24.07

mmol/l

34.66

1688

5823

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1203

3274

4.03

307.65

3.7

2.5

—

(3016502) Oxygen saturation in Arterial blood

2565

10363

2.96

307.65

10.4

8.6

93.37

95.95

65.93

2489

10025

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2101

6609

3.74

307.65

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2713

11547

2.83

307.65

2.7

1.8

—

(3023368) Bacteria identified in Blood by Culture

4822

26768

2.50

307.65

6.3

4.4

—

(3009343) pH of Capillary blood

1765

6078

3.30

307.65

5.9

3.4

7.41

7.42

4.15

1556

5011

(3003396) Base excess in Arterial blood by calculation

2921

11386

3.18

307.65

10.1

8.2

2.00

0.71

mmol/l

48.54

2574

9391

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2919

11503

3.14

307.65

10.2

8.2

5.49

5.04

kpa

75.61

2816

11099

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1826

6262

3.33

307.65

6.0

3.4

5.50

5.07

kpa

57.55

1781

5961

(3019977) pH of Arterial blood

2912

11489

3.14

307.65

10.2

8.2

7.41

7.42

4.65

1806

6066

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1606

5253

3.44

307.65

5.3

3.2

2.73

1.50

mmol/l

27.75

1298

3787

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2511

10830

2.74

307.65

2.8

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2917

11497

3.14

307.65

10.2

8.2

9.96

12.72

kpa

219.61

2809

11079

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1170

3281

3.89

307.65

4.5

2.7

26.08

24.36

mmol/l

32.95

1156

3223

(42870588) Differential panel, method unspecified - Blood

4945

31450

2.10

285.94

7.9

6.5

—

4.20

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2159

9779

2.53

284.94

11.8

9.0

126.25

121.39

g/l

19.76

2123

9557

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

572

1100

5.45

282.33

1.2

1.1

—

(3022313) Gas panel - Capillary blood

1218

4296

3.08

258.55

6.3

3.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

1359

5141

2.89

254.26

1.6

1.3

336.16

262.44

u/ml

1.18

1277

4775

(3013115) Eosinophils [#/volume] in Blood

6622

48058

2.05

254.07

9.0

6.6

0.20

e9/l

0.90

5933

41712

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4571

29142

2.02

252.90

4.0

3.1

1496.61

1375.41

ng/l

0.76

4037

25192

(3019069) Monocytes/Leukocytes in Blood

6082

42862

2.02

252.89

8.8

6.8

8.79

9.07

11.58

5822

40146

(3006504) Eosinophils/Leukocytes in Blood

6056

42756

2.01

248.75

8.7

6.7

2.54

2.92

33.61

5790

40019

(3022096) Basophils/Leukocytes in Blood

6051

42780

2.00

246.68

8.8

6.8

0.63

0.68

11.13

5791

40032

(3028626) Oxygen [Partial pressure] in Capillary blood

780

2171

3.80

240.53

4.6

2.8

7.60

8.21

kpa

24.98

761

2116

(3006315) Basophils [#/volume] in Blood

6434

46741

2.00

239.28

8.5

6.5

0.05

0.04

e9/l

28.97

5684

39901

(3001604) Monocytes [#/volume] in Blood

6418

46589

2.00

239.16

8.5

6.4

0.69

0.60

e9/l

106.37

5655

39779

(3002030) Lymphocytes/Leukocytes in Blood

6092

43742

1.96

230.55

8.8

6.7

24.06

27.41

115.27

5875

41407

(3018010) Neutrophils/Leukocytes in Blood

5995

42893

1.95

228.34

8.6

6.6

60.90

57.34

105.21

5801

40943

(3019198) Lymphocytes [#/volume] in Blood

6472

47607

1.96

225.92

8.6

6.5

1.90

1.91

e9/l

0.10

5799

41650

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

437

811

5.58

223.76

4.4

3.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

640

1627

4.13

223.75

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

640

1627

4.13

223.75

1.7

1.3

—

(3021901) Oxygen saturation in Capillary blood

685

1893

3.80

212.90

4.4

2.8

88.36

90.28

11.56

671

1839

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

38.71

212.27

1.8

1.6

42.21

57.68

umol/l

1.75

130

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1484

6501

2.50

204.72

11.7

8.6

26.01

24.61

mmol/l

28.15

1472

6465

(3002032) Base excess in Venous blood by calculation

1936

9594

2.25

201.27

5.3

4.1

2.63

1.61

mmol/l

19.07

1722

8399

(3000991) Gas panel - Venous blood

1800

8656

2.31

201.05

13.2

9.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1968

9847

2.23

199.69

5.3

4.1

6.22

5.75

kpa

46.24

1905

9631

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2854

16460

2.01

199.08

4.8

3.6

0.79

0.82

mmol/l

21.38

2695

15583

(3014111) Lactate [Moles/volume] in Serum or Plasma

1851

9053

2.27

198.37

11.7

8.2

1.35

1.36

mmol/l

0.29

1806

8867

(3012544) pH of Venous blood

1983

10066

2.20

193.56

5.3

4.1

7.37

7.38

2.49

1206

5789

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

754

2395

3.32

188.91

2.0

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

685

2064

3.48

186.56

1.8

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

689

2117

3.42

181.91

1.8

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1370

6102

2.44

180.88

9.9

7.1

25.89

24.31

mmol/l

32.58

1328

5844

(3013650) Neutrophils [#/volume] in Blood by Automated count

6728

52013

1.84

179.87

12.9

10.1

5.04

4.11

e9/l

108.20

6022

44937

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

753

2468

3.21

178.96

2.0

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1285

5652

2.45

174.02

2.3

1.7

—

(3032080) INR in Blood by Coagulation assay

6027

45368

1.79

172.78

18.5

15.7

1.26

1.27

inr

1.57

5198

37851

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

608

1793

3.54

170.91

1.8

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6461

49730

1.80

170.75

8.3

7.1

10.54

12.13

umol/l

16.23

6203

47595

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5711

42439

1.77

169.91

10.9

7.0

1.20

1.21

mmol/l

24.40

5381

39408

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

905

3388

2.83

169.74

6.2

3.5

25.32

24.69

mmol/l

7.82

858

3089

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3120

19532

1.86

164.40

2.1

1.8

1.23

1.31

mg/l

0.65

2523

15333

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1430

6770

2.29

163.13

14.0

10.1

1.80

1.27

37.17

1422

6730

(3042631) Mycobacterium sp identified in Specimen

480

1243

4.00

162.94

3.6

2.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1397

6561

2.31

162.36

14.3

10.4

0.59

0.63

3.76

1388

6523

(3014007) Fractional oxyhemoglobin in Arterial blood

1434

6820

2.28

161.73

14.2

10.2

91.45

94.26

43.91

1429

6804

(1616796) Gas panel - Central venous blood

649

2070

3.28

160.98

5.7

3.6

—

(3042936) Bacteria identified in Isolate by Culture

2403

13946

1.94

159.13

2.5

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1286

5974

2.32

152.79

13.6

10.5

16.03

16.12

0.51

1255

5768

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6121

47231

1.73

151.38

11.2

7.8

1.20

1.21

mmol/l

37.48

5399

40877

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1246

5739

2.33

150.90

5.3

4.3

24.76

24.06

mmol/l

9.08

1222

5683

(3006184) Hemoglobin [Mass/volume] in Capillary blood

651

2229

3.05

142.92

2.9

2.2

134.12

129.72

g/l

3.39

453

1711

(3000963) Hemoglobin [Mass/volume] in Blood

8665

94403

0.49

138.06

47.0

25.7

134.62

136.55

g/l

23.37

8588

93440

(3026361) Erythrocytes [#/volume] in Blood

8664

94390

0.49

137.80

46.5

25.6

4.47

4.51

e12/l

11.60

8503

92164

(3035941) MCH [Entitic mass]

8664

94382

0.49

137.42

46.4

25.5

30.46

30.49

0.48

8585

93409

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8665

94388

0.49

137.36

48.1

26.1

40.61

41.00

2.22

8584

93369

(3010813) Leukocytes [#/volume] in Blood

8667

94400

0.49

137.24

46.7

25.6

8.04

6.70

e9/l

236.02

8508

92161

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8665

94383

0.49

137.13

46.4

25.5

92.16

91.42

37.21

8586

93410

(3007461) Platelets [#/volume] in Blood

8663

94357

0.49

136.59

46.6

25.6

262.09

243.80

e9/l

96.21

8530

92458

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

239

402

6.06

135.39

4.4

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1448

7464

2.09

131.43

3.8

2.9

227.83

194.01

ng/l

1.52

1324

6825

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4205

30140

1.67

129.92

3.7

2.7

68.44

67.15

u/l

0.03

3898

28058

(3007853) Bacteria identified in Skin by Aerobe culture

1913

10986

1.91

127.27

2.1

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2873

18671

1.75

127.20

5.8

3.9

403.43

546.43

ng/l

0.96

2352

15081

(3024561) Albumin [Mass/volume] in Serum or Plasma

5508

42483

1.64

125.70

6.6

5.5

33.86

35.58

g/l

84.20

5186

39912

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2183

13121

1.84

125.70

7.5

6.7

1.07

1.03

mmol/l

6.43

2067

12307

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

547

1823

3.11

125.56

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7998

88953

0.55

124.46

6.6

6.2

2.47

2.67

mmol/l

68.25

7367

83083

(3024354) Oxygen [Partial pressure] in Venous blood

1529

8199

2.02

124.04

4.7

3.3

4.77

4.56

kpa

2.56

1465

8003

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

438

1285

3.52

123.62

1.1

1.55

1.52

g/l

0.65

401

1179

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7847

87688

0.56

122.86

5.8

5.5

4.36

4.57

mmol/l

57.19

7251

82271

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1014

4659

2.30

122.26

1.8

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7791

87193

0.57

121.62

5.7

5.4

1.36

1.42

mmol/l

31.22

7150

81254

(3020779) Urea [Moles/volume] in Serum or Plasma

1683

9397

1.95

121.27

9.1

8.1

10.26

10.25

mmol/l

0.01

1612

9028

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

502

1631

3.18

120.24

2.1

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

471

1474

3.30

120.01

1.6

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6794

55649

1.65

118.04

9.6

5.3

6.94

6.81

mmol/l

5.32

6566

53157

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1846

10724

1.88

117.55

2.4

1.8

1.81

1.49

29.35

1552

9322

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

407

1186

3.53

116.01

2.2

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

405

1182

3.53

115.16

2.1

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

405

1182

3.53

115.16

2.1

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

405

1182

3.53

115.16

2.1

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

405

1182

3.53

115.16

2.1

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

837

3636

2.42

114.45

2.6

2.3

449.41

713.99

ug/l

1.77

794

3460

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1294

6724

2.06

113.85

1.9

1.7

—

(4015189) Microbial culture of sputum

148

178

8.42

113.74

3.0

1.9

—

(3003129) Base excess in Capillary blood by calculation

403

1190

3.48

112.53

2.9

2.2

1.35

0.24

mmol/l

7.02

397

1142

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

222

420

5.38

110.99

17.6

19.6

1405.76

1403.88

nmol/l

0.01

212

410

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

896

4089

2.30

109.30

2.3

1.9

1.77

2.27

ug/l

0.81

822

3661

(3027315) Oxygen [Partial pressure] in Blood

535

1932

2.87

106.22

6.9

3.8

8.15

8.69

kpa

11.68

524

1893

(3023183) Ammonium ion [Moles/volume] in Plasma

595

2275

2.71

105.96

2.5

2.9

33.40

34.84

umol/l

0.75

537

2051

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

391

1177

3.41

105.91

2.1

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

530

1920

2.86

104.59

6.9

3.8

5.34

4.94

kpa

18.81

519

1882

(3012501) Base excess in Blood by calculation

530

1920

2.86

104.59

6.9

3.8

3.06

2.41

mmol/l

5.24

426

1265

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

246

538

4.66

103.87

1.6

1.3

2.04

1.24

u/ml

0.74

167

303

(40767503) Oxygen content in Capillary blood by calculation

531

1942

2.83

102.92

3.8

2.5

16.53

16.47

0.18

519

1899

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1637

9525

1.85

102.35

2.4

0.21

g/l

0.20

1501

8923

(3009466) Valproate [Moles/volume] in Serum or Plasma

401

1257

3.28

101.76

6.6

5.0

359.83

355.89

umol/l

0.20

353

1078

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8627

93230

0.55

101.28

39.7

22.2

81.10

81.36

umol/l

0.18

8533

92239

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1466

8269

1.90

100.91

2.7

2.4

356.39

376.11

nmol/l

2.47

1344

7710

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4739

36486

1.55

99.63

5.8

3.7

61.52

75.18

ng/l

0.24

3713

26687

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

205

403

5.17

98.18

12.8

15.0

812.23

4075.74

nmol/l

0.50

198

385

(1761868) Lipid panel - Serum or Plasma

2404

34521

0.60

97.04

3.7

3.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8533

92357

0.56

96.35

18.0

12.8

27.06

27.53

u/l

1.01

8345

89781

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4186

31530

1.55

95.95

4.4

3.4

38.95

35.45

u/l

0.59

3932

29703

(3028707) Methadone [Presence] in Urine by Screen method

310

859

3.69

95.21

3.2

2.4

—

(3000494) Fungus identified in Specimen by Culture

1872

11574

1.75

94.81

2.0

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

518

2009

2.66

89.47

1.4

1.1

—

(3020891) Body temperature

926

4646

2.09

88.44

7.3

4.5

36.97

36.90

°c

7.59

912

4607

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

389

1305

3.06

87.98

1.9

2.0

25.59

26.39

ug/l

0.08

381

1274

(3017569) Oxygen content in Arterial blood

216

492

4.46

86.70

2.6

2.2

17.00

15.90

4.69

216

492

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

759

3561

2.22

85.98

2.6

2.0

—

(3026008) Bacteria identified in Urine by Culture

3479

25664

1.54

84.76

3.9

3.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7537

83593

0.64

82.77

4.9

4.6

1.48

1.32

mmol/l

50.39

6826

77160

(3018405) Lactate [Moles/volume] in Arterial blood

691

3192

2.25

81.19

6.3

4.0

1.39

1.42

mmol/l

0.25

679

3138

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

703

3280

2.23

80.60

2.5

1.8

—

(3047181) Lactate [Moles/volume] in Blood

645

2914

2.29

79.89

7.6

6.3

1.30

1.34

mmol/l

0.47

583

2561

(3018418) pH of Serum or Plasma

3741

28336

1.50

78.96

5.6

4.6

7.40

0.03

2858

20323

(3010421) pH of Blood

655

3002

2.26

78.37

6.8

3.6

7.41

0.52

645

2969

(3026782) Osmolality of Urine

2607

18299

1.57

78.14

3.7

3.0

502.53

546.61

mosm/kgh2o

19.61

2305

16163

(3022948) Iron [Moles/volume] in Serum or Plasma

2405

16602

1.58

77.37

3.2

2.8

11.39

13.22

umol/l

23.65

2248

15557

(46235355) HIV 1 and 2 tests - Meaningful Use set

1859

12068

1.66

76.83

1.8

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

686

3.66

75.59

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2273

15579

1.59

75.05

1.9

1.7

1099.05

1157.80

nmol/l

2.37

1708

11944

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3223

23892

1.51

74.40

2.8

2.3

3.12

2.79

mg/l

9.15

2829

20667

(3005719) IgG [Mass/volume] in Serum or Plasma

1234

7231

1.80

73.55

3.1

2.9

9.92

10.64

g/l

7.56

1156

6680

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2128

14451

1.60

72.76

3.3

2.8

19.98

23.24

21.27

1988

13507

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

260

780

3.39

70.73

2.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

427

1691

2.59

70.54

1.5

1.3

52.58

63.41

mmol/l

5.80

304

1362

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2253

15609

1.57

70.34

3.2

2.7

2.33

2.29

g/l

3.33

2086

14490

(3028271) Lactate [Moles/volume] in Capillary blood

379

1419

2.73

70.02

2.4

1.8

1.61

1.77

mmol/l

2.99

370

1375

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3891

30306

1.46

68.51

3.0

2.3

248.50

216.78

u/l

1.00

3676

28696

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1816

26232

0.63

68.24

2.9

3.3

0.68

0.77

ug/l

2.95

1220

17541

(3028026) IgM [Mass/volume] in Serum or Plasma

1000

5647

1.85

66.92

2.0

1.19

1.31

g/l

1.30

922

5182

(3009445) Proteinase 3 Ab [Units/volume] in Serum

784

4105

1.98

65.89

1.4

1.6

6.01

17.27

iu/ml

2.42

106

(44816559) Phosphatidylethanol [Mass/volume] in Blood

754

3902

2.01

65.50

2.1

1.7

0.38

0.33

mg/l

1.25

434

1949

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2649

35082

0.67

64.87

4.0

4.6

20.33

22.04

6.50

1138

17762

(3017181) Myelocytes/Leukocytes in Blood

1383

8670

1.69

64.29

5.0

4.4

0.97

0.01

513

2745

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2184

15344

1.54

63.04

2.5

2.2

30.26

29.82

2.47

2129

14959

(3002179) Metamyelocytes/Leukocytes in Blood

1325

8278

1.69

62.25

4.6

4.3

0.79

0.73

0.21

490

2629

(3004119) Hemoglobin [Mass/volume] in Venous blood

1058

6215

1.78

61.95

4.6

3.4

130.19

129.58

g/l

0.36

1024

6040

(3027273) Bicarbonate [Moles/volume] in Venous blood

811

4386

1.92

61.87

4.8

3.5

26.38

25.01

mmol/l

16.10

787

4245

(3037692) Legionella sp identified in Specimen by Organism specific culture

145

316

4.64

61.55

2.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

667

3380

2.04

61.34

3.5

3.2

0.32

0.34

iu/ml

1.36

371

1867

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

412

8966

0.44

60.45

1.9

2.1

3.62

3.53

ratio

0.62

334

7230

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

816

4477

1.89

59.51

6.7

5.3

2.15

1.58

21.07

780

4228

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

577

2808

2.12

59.11

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

247

807

3.11

58.44

1.8

1.4

1.46

1.25

promille

1.27

195

632

(3011288) Drugs identified in Urine by Screen method Nominal

340

1320

2.63

58.44

3.5

2.6

—

(4198724) Urine methamphetamine measurement

125

255

4.95

57.44

2.1

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6458

72463

0.71

57.25

41.5

21.5

329.94

332.93

g/l

105.46

6404

72116

(1001926) Buprenorphine [Presence] in Urine by Screen method

378

1561

2.48

57.13

2.9

1.8

—

(3021440) Promyelocytes/Leukocytes in Blood

1303

8284

1.66

56.90

5.1

4.5

0.11

0.12

0.21

435

2367

(3022806) Fractional oxyhemoglobin in Capillary blood

293

1070

2.79

56.76

2.3

1.8

88.54

89.63

2.71

288

1054

(3043409) Potassium [Moles/volume] in Arterial blood

551

2676

2.12

56.71

7.0

4.3

3.97

3.90

mmol/l

2.63

546

2650

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

162

410

4.00

56.66

2.1

1.7

113.75

112.86

umol/l

0.01

189

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1400

9077

1.63

56.51

3.3

2.6

50.67

55.46

u/l

0.09

1173

7733

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1663

11286

1.56

55.24

2.8

3.0

9.29

9.30

umol/l

0.01

1410

10070

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

227

733

3.14

54.80

1.8

1.5

—

(3025159) Blasts/Leukocytes in Blood

1302

8354

1.64

54.68

5.3

4.6

0.24

0.31

0.19

407

2251

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

661

3475

1.96

54.66

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1728

11883

1.55

53.98

3.9

4.9

240.26

244.83

u/l

0.52

1637

11313

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7943

85737

0.68

53.81

6.2

5.5

6.29

6.03

mmol/l

39.85

7237

79065

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

105

7.38

53.27

1.5

1.3

54.87

38.17

mg/l

1.47

(3002582) Erythrocytes [#/volume] in Urine

3920

31609

1.39

52.46

4.6

3.5

59.86

90.89

e6/l

1.40

3089

24358

(3000850) Epithelial cells [#/volume] in Urine

2868

21929

1.43

52.26

3.5

2.8

5.90

4.33

e6/l

8.07

2632

20079

(3016879) Cocaine [Presence] in Urine

419

1887

2.27

52.02

3.0

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

3141

24435

1.41

51.80

6.5

4.3

88.43

87.83

0.62

3061

23936

(40761511) CBC panel - Blood by Automated count

8349

89153

0.67

51.62

26.8

15.0

—

6.29

—

(3024928) Oxygen saturation in Venous blood

513

2550

2.06

49.56

4.1

3.5

63.83

62.29

0.79

483

2488

(3000764) Benzodiazepines [Presence] in Urine

430

2026

2.17

47.77

3.0

1.8

—

(21494755) Public health laboratory ask at order entry panel

345

7356

0.45

47.28

1.3

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

719

4071

1.82

47.14

7.2

5.6

0.83

0.88

3.28

685

3839

(3052851) Hemolysis interference index of Serum or Plasma

508

2567

2.03

46.90

4.5

3.3

2.43

2.23

index

0.25

303

1322

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7947

85381

0.70

46.76

29.5

16.6

82.15

79.14

ml/min/173m2

30.94

7527

79587

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

527

2704

2.00

46.61

1.4

1.5

10.34

13.20

iu/ml

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4207

34769

1.35

46.40

4.5

3.6

—

1.34

—

(3027945) Reticulocytes/Erythrocytes in Blood

1661

11663

1.51

46.34

2.8

2.6

1.93

1.76

6.92

1487

10457

(3027008) Opiates [Presence] in Urine

428

2038

2.15

46.28

3.0

1.8

—

(3028300) Cannabinoids [Presence] in Urine

429

2046

2.14

46.20

3.1

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

104

6.87

46.07

3.4

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

3409

27301

1.37

45.85

4.4

3.4

0.61

0.42

e6/l

3.43

2617

20182

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

225

802

2.85

45.65

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

225

802

2.85

45.65

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

225

802

2.85

45.65

1.5

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

280

6371

0.42

45.34

1.6

1.8

3.43

3.46

mmol/l

0.13

205

4581

(3031040) Bacteria [#/volume] in Urine by Automated count

6574

58239

1.35

45.09

6.4

4.6

1906.84

1182.52

e6/l

0.38

126

851

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

176

549

3.24

45.06

1.8

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

621

3.10

44.99

1.8

1.4

—

(36304419) Bacteria [Presence] in Urine

3232

25738

1.37

44.77

4.4

3.3

0.33

402.65

estimate

0.80

106

(3039000) Anion gap in Blood by calculation

424

2039

2.13

44.69

8.2

7.6

10.88

11.35

mmol/l

1.96

391

1827

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

567

3.20

44.68

1.8

1.5

—

(3018572) Chloride [Moles/volume] in Blood

424

2040

2.12

44.63

8.2

7.6

103.91

105.41

mmol/l

7.31

391

1828

(3027944) Amphetamines [Presence] in Urine

418

2007

2.13

44.24

3.1

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

247

940

2.67

44.21

1.6

1.4

2.63

2.98

g/l

2.30

181

664

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1268

8480

1.56

44.12

2.9

2.3

7.87

8.46

ug/l

0.37

1114

7564

(3023103) Potassium [Moles/volume] in Serum or Plasma

8567

90640

0.68

43.86

38.9

20.2

4.01

3.99

mmol/l

7.73

8448

88916

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7889

84683

0.71

43.71

8.5

6.8

41.66

39.74

mmol/mol

52.97

7314

79353

(3024139) IgG subclass 3 [Mass/volume] in Serum

246

940

2.66

43.68

1.6

1.4

0.40

0.42

g/l

0.32

182

663

(3027135) IgG subclass 1 [Mass/volume] in Serum

246

941

2.65

43.59

1.6

1.4

6.32

6.90

g/l

1.63

180

666

(4062490) Immunoglobulin typing, IgG

242

920

2.67

43.41

1.6

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

366

1681

2.22

43.32

3.4

3.1

0.83

0.80

nmol/l

0.65

304

1316

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

817

4934

1.71

42.75

5.9

3.9

51.50

47.54

4.71

802

4864

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3631

43561

0.74

42.57

4.7

5.6

3.20

3.23

ug/l

0.01

3166

39713

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

238

909

2.66

42.31

2.0

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3861

31813

1.34

42.17

3.7

3.8

2.35

mmol/l

0.73

3475

29022

(3024980) IgG subclass 4 [Mass/volume] in Serum

344

1561

2.25

41.93

1.7

1.6

0.77

0.86

g/l

0.62

267

1206

(3040151) Glucose [Moles/volume] in Capillary blood

259

1046

2.51

41.08

32.5

5.9

8.10

7.48

mmol/l

0.59

223

852

(40758558) Short blood count panel - Blood

3470

28222

1.35

41.04

8.8

6.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

246

970

2.57

41.01

2.0

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2215

16787

1.41

40.62

1.7

1.5

2.73

2.56

g/l

1.83

1368

10401

(3019550) Sodium [Moles/volume] in Serum or Plasma

8564

90445

0.69

40.60

38.9

19.9

138.96

139.76

mmol/l

117.46

8451

88865

(3020630) Protein [Mass/volume] in Serum or Plasma

1259

8595

1.53

39.63

2.1

2.8

64.97

66.44

g/l

9.03

1171

7925

(3017143) Hepatitis C virus Ab [Presence] in Serum

1331

9202

1.51

39.47

1.7

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

521

2817

1.89

39.43

2.7

2.6

3.73

3.59

g/l

1.32

492

2700

(3037522) Nuclear Ab [Titer] in Serum

1714

12481

1.45

39.08

1.4

494.75

499.05

titre

0.03

396

2614

(3018095) Leukocytes [#/volume] in Urine

4185

35161

1.32

38.94

5.5

4.1

81.10

91.48

e6/l

0.58

3146

25397

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1380

9684

1.49

37.95

4.8

3.4

—

(40757373) Influenza virus identified in Isolate

156

5.03

36.78

2.4

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1626

11864

1.44

36.42

4.1

3.3

5.66

4.49

e9/l

3.56

1378

10272

(3008536) Aspergillus sp Ab [Presence] in Serum

190

4.56

36.03

1.7

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

154

513

3.03

35.37

2.3

2.0

7.58

8.06

mmol/l

1.00

154

513

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1478

10677

1.45

34.78

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

517

2905

1.82

34.60

1.9

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

299

1407

2.16

33.34

1.4

1.5

34.84

32.96

g/l

1.80

268

1274

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

192

745

2.61

33.15

1.5

1.4

11.58

12.93

u/l

2.29

187

721

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7709

71130

1.33

33.11

12.0

8.8

83.77

80.07

u/l

6.82

7427

67690

(40760892) CBC W Ordered Manual Differential panel - Blood

2510

19969

1.34

32.82

6.2

4.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

268

1219

2.23

32.53

1.4

1.5

4958.35

2709.71

e6/l

0.62

190

834

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

353

1788

2.01

32.35

1.3

1.2

53.33

210.00

titre

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

351

1780

2.01

32.06

1.3

1.2

224.80

340.45

titre

0.48

122

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2036

15784

1.36

31.36

4.0

3.2

2.55

1.83

e6/l

3.05

1065

7831

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

279

3.65

31.35

4.1

2.8

9.37

10.49

kpa

1.83

101

279

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

279

3.65

31.35

4.1

2.8

5.45

4.86

kpa

4.15

101

279

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

303

1478

2.08

30.79

6.3

6.5

11.99

11.73

mg/l

0.42

277

1378

(3000570) Elastase.pancreatic [Mass/mass] in Stool

515

3004

1.75

30.34

1.5

1.4

269.44

266.59

ug/g

0.11

309

1797

(3016038) Potassium [Moles/volume] in Urine

163

610

2.70

30.28

1.2

31.46

34.88

mmol/l

1.07

141

533

(3044640) Blood type and Crossmatch panel - Blood

3586

30238

1.28

30.00

3.2

2.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

494

2887

1.75

28.91

2.7

2.2

91.42

90.89

0.19

479

2782

(3036489) Thrombin time

571

3489

1.67

28.38

2.5

2.1

20.76

21.22

1.00

514

3108

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

563

2.71

28.28

2.4

1.8

—

(3021589) Normoblasts [#/volume] in Blood

4649

40677

1.26

28.03

17.3

12.0

0.01

0.00

e9/l

0.45

3794

33218

(3019225) pH of Specimen

1225

8871

1.43

28.01

4.5

7.37

7.35

1.34

950

6477

(3028308) Erythrocytes [#/volume] in Pleural fluid

236

1090

2.19

27.64

1.4

1.5

86290.12

57589.97

e6/l

0.30

137

599

(3024666) Lithium [Moles/volume] in Serum or Plasma

122

412

2.98

27.46

15.4

13.5

0.63

0.65

mmol/l

0.39

113

381

(3021960) Folate [Moles/volume] in Serum or Plasma

3216

26975

1.28

27.42

1.9

1.7

18.30

20.03

nmol/l

7.98

2757

22895

(3004809) Band form neutrophils/Leukocytes in Blood

321

1667

1.96

27.42

3.0

3.7

1.50

1.69

0.35

287

1502

(3023520) Reticulocytes [#/volume] in Blood

1256

9184

1.42

27.16

2.6

2.7

75.28

68.85

e9/l

6.89

917

6847

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

218

982

2.25

27.15

1.3

708.27

436.63

u/l

0.45

209

936

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2803

23202

1.29

26.32

3.1

2.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

132

479

2.78

26.07

1.5

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

479

2.78

26.07

1.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

132

479

2.78

26.07

1.5

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

132

479

2.78

26.07

1.5

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

212

963

2.23

25.89

3.2

4.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1384

10372

1.39

25.83

3.1

4.6

32.73

24.95

ug/l

0.27

1233

8574

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2267

18299

1.31

25.70

3.3

3.2

2.48

2.45

mmol/l

21.77

1999

16507

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

384

2164

1.80

25.45

11.5

5.7

327.36

1730.33

iu/ml

1.08

330

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

7.06

25.39

1.4

1.8

—

(40768797) Stomach Pathology biopsy report

1704

13249

1.34

25.09

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

447

2645

1.72

25.02

2.8

2.5

209.07

200.09

1.26

424

2524

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

381

2157

1.80

24.87

1.7

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

300

1576

1.93

24.80

1.4

10.67

10.36

u/ml

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6676

61322

1.25

24.60

6.0

4.5

1.20

2.48

—

(3042733) HLA Ab [Presence] in Serum

105

347

3.05

24.58

4.6

5.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

450

2691

1.70

24.24

1.7

0.24

g/l

0.30

428

2566

(3001964) Herpes simplex virus Ag [Presence] in Specimen

230

3.54

24.22

2.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4737

41992

1.24

23.90

2.5

2.1

90.75

95.24

pmol/l

9.50

2778

22820

(40768806) Pleura Pathology biopsy report

220

1056

2.11

23.42

1.5

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

457

2784

1.67

22.97

1.7

1.6

1.21

1.20

g/l

0.35

436

2664

(3008295) Osmolality of Serum or Plasma

214

1031

2.10

22.57

1.3

1.4

271.93

279.53

mosm/kgh2o

3.46

164

804

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

172

763

2.28

22.30

1.2

1.3

13.55

12.90

u/l

0.15

159

711

(3009508) Creatinine [Moles/volume] in Urine

4004

35042

1.23

22.22

3.9

3.5

7.07

7.90

mmol/l

27.41

3299

29635

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7173

66730

1.25

22.07

6.2

4.4

16.00

12.11

mm/h

66.82

6763

62460

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

694

4709

1.51

21.99

1.7

1.70

1.53

g/l

4.55

613

4058

(3001019) Free T4 and TSH panel - Serum or Plasma

175

3622

0.47

21.70

1.5

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3929

34377

1.23

21.69

4.5

4.3

15.94

8.02

mg/mmol

8.61

2564

21852

(3026389) Candida sp identified in Specimen by Organism specific culture

235

1190

2.00

21.66

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

876

6244

1.44

21.60

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

205

989

2.09

21.57

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

454

2814

1.64

21.34

1.6

1.5

2.45

6.18

iu/ml

0.50

537

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

613

4081

1.53

21.24

2.0

38.20

39.48

u/l

0.85

526

3593

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

305

3.00

20.86

2.9

2.7

150.56

142.92

nmol/l

0.34

268

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

115

442

2.62

20.41

1.7

1.4

1801999.85

1088731.41

iu/ml

0.50

(3017354) Segmented neutrophils/Leukocytes in Blood

213

1071

2.01

20.06

2.8

3.7

60.14

57.83

0.92

183

934

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

969

7124

1.40

20.01

4.7

4.3

103.69

94.05

ng/l

1.82

837

6191

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

419

2598

1.64

19.68

2.1

2.0

11.96

12.04

mg/l

0.06

394

2428

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2100

17317

1.27

19.31

3.9

3.1

1.08

1.02

e6/l

0.26

1148

9385

(3036782) Glucose [Moles/volume] in Pleural fluid

198

987

2.03

19.12

1.3

1.4

6.62

6.30

mmol/l

0.67

184

912

(3010726) Horse dander IgE Ab [Units/volume] in Serum

215

1114

1.95

18.61

1.1

1.84

1.03

u/ml

1.39

133

537

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

594

4039

1.50

18.61

2.1

2.5

3.15

2.84

g/l

10.27

548

3686

(3017446) Testosterone [Moles/volume] in Serum or Plasma

782

10665

0.71

18.06

2.7

2.3

12.48

13.49

nmol/l

3.07

675

9664

(3051611) Lipemic interference index of Serum or Plasma

185

920

2.03

18.01

4.7

3.5

13.54

13.25

index

0.14

136

514

(3026493) Urate [Moles/volume] in Serum or Plasma

3090

26753

1.22

17.98

3.6

2.9

363.79

351.40

umol/l

7.74

2672

23689

(3042517) Benzodiazepines panel - Urine

6.27

17.98

4.0

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

427

2724

1.59

17.87

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

619

4296

1.47

17.51

2.0

2.5

4.28

4.19

g/l

1.84

573

3947

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

619

4303

1.47

17.37

2.1

2.5

7.87

7.26

g/l

13.36

573

3945

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

617

4290

1.47

17.29

2.0

2.5

3.92

3.72

g/l

1.37

571

3937

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

291

1697

1.74

17.25

4.8

2.7

486.19

6330.29

u/ml

0.61

108

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

166

3.51

17.25

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

318

1903

1.69

17.16

1.5

1.4

17.83

19.04

u/ml

0.10

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

301

2.81

17.15

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

172

850

2.04

17.06

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

318

1912

1.68

16.87

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

124

2643

0.46

16.74

1.1

1.2

0.65

0.63

ratio

0.12

442

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

254

1438

1.79

16.70

1.1

2.12

1.76

u/ml

0.21

157

767

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6792

72083

0.83

16.60

38.8

20.6

14.35

13.66

221.42

6729

71153

(3012516) Albumin [Mass/volume] in Urine

3810

33852

1.20

16.56

3.8

3.6

78.57

46.61

mg/l

7.65

2593

22030

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

347

2.64

16.50

1.6

2.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.93

16.48

2.3

3.4

1.78

2.42

mg/l

0.99

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3553

39899

0.83

16.44

2.1

2.0

1.53

1.37

mmol/l

16.58

2930

33275

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

430

2809

1.55

16.26

2.3

2.5

0.00

g/l

-0.00

409

2618

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

403

2600

1.57

16.10

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

539

3703

1.48

16.06

2.2

2.5

0.51

0.88

g/l

1.89

480

3178

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

470

3142

1.52

15.99

2.3

2.5

0.09

0.03

g/l

0.43

438

2807

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

586

2.22

15.93

1.7

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

315

2.68

15.76

1.0

1.1

5.85

3.99

u/ml

0.45

(3024932) HLA-DR beta [Type]

327

2.64

15.70

1.1

—

(40768800) Prostate Pathology biopsy report

157

3017

0.51

15.64

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

220

1218

1.82

15.60

1.1

4.49

3.79

u/ml

0.23

127

600

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

346

2.59

15.55

1.6

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

346

2.59

15.55

1.6

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

286

1710

1.69

15.52

1.6

1.5

155.74

150.64

au/ml

0.30

525

(3035880) pH of Pleural fluid

120

536

2.25

15.45

1.3

7.39

0.01

363

(3008401) Mugwort IgE Ab [Units/volume] in Serum

215

1186

1.83

15.43

1.1

0.76

1.14

u/ml

0.66

102

501

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

452

3020

1.52

15.42

2.3

2.5

0.00

g/l

0.35

411

2625

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

221

1230

1.81

15.41

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.73

15.36

1.2

1.1

1.33

1.63

iu/ml

0.34

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.42

15.35

1.2

0.11

0.88

iu/ml

1.55

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

127

583

2.19

15.31

1.7

2.8

601.46

528.14

e6/l

0.87

103

473

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

3667

1.47

15.24

2.1

2.5

9.64

10.24

g/l

2.44

484

3285

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6441

60165

1.19

15.18

5.0

3.4

70.17

53.18

u/l

19.64

6057

56441

(3048929) Epstein Barr virus Ab [Presence] in Serum

376

2423

1.57

15.11

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

316

1953

1.64

15.11

1.4

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

206

1136

1.83

14.82

2.5

1.9

23.39

27.63

mg/l

0.65

414

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

129

604

2.15

14.81

1.8

2.9

232.18

241.65

e6/l

0.18

108

526

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2285

19511

1.22

14.70

1.9

1.7

49601697.75

30387232.67

pmol/l

0.65

1881

16313

(3024471) HLA-A [Type]

333

2.54

14.14

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.83

13.97

1.4

1.6

0.33

1.19

mg/l

0.85

(3023430) Cat dander IgE Ab [Units/volume] in Serum

174

928

1.89

13.94

1.1

1.0

6.34

3.16

u/ml

1.19

104

390

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5340

49303

1.17

13.81

3.4

2.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

410

2750

1.51

13.77

1.2

179.75

137.04

titre

0.34

260

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2210

18916

1.21

13.75

1.3

1.68

1.89

u/ml

0.31

526

5084

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

220

1267

1.75

13.72

1.2

1.1

114.84

116.78

0.37

206

1145

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

0.89

0.71

mg/l

0.12

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

2.47

4.02

mg/l

0.60

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

3.61

1.90

mg/l

0.66

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

1.09

2.41

mg/l

0.75

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

2.28

2.05

mg/l

0.08

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

2.75

1.25

mg/l

0.58

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

0.85

0.49

mg/l

0.27

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

0.64

1.95

mg/l

0.89

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.86

13.50

1.4

1.6

1.06

2.75

mg/l

0.99

(40757494) Bilirubin.total [Moles/volume] in Blood

107

485

2.22

13.37

2.7

2.2

14.94

46.87

umol/l

1.37

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

960

7484

1.31

13.36

5.3

4.2

1.21

1.23

mmol/l

6.72

876

6503

(3014133) Dog dander IgE Ab [Units/volume] in Serum

181

994

1.84

13.25

1.1

5.59

3.05

u/ml

1.18

117

471

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7724

80552

0.84

13.05

6.1

5.1

1.81

1.96

mu/l

22.84

7080

74319

(3034770) Mitochondria Ab [Titer] in Serum

400

2706

1.50

12.91

1.2

586.32

883.04

titre

0.82

(4195642) Thrombophilia screening test

215

1259

1.72

12.67

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.92

12.67

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

229

1365

1.69

12.65

1.9

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4393

40140

1.16

12.46

3.8

3.1

145.75

156.49

ug/l

1.39

4048

37391

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

271

1698

1.61

12.33

1.2

1.3

311.45

282.06

u/ml

0.70

168

1055

(3023420) DNA double strand Ab [Units/volume] in Serum

510

3649

1.42

12.29

2.0

1.7

6.56

7.04

iu/ml

0.16

111

852

(3011412) CD3 cells [#/volume] in Blood

161

875

1.85

12.22

1.8

2.6

1328.16

1130.39

e6/l

1.82

140

780

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

671

5033

1.36

12.16

3.3

3.6

4.36

4.46

pmol/l

2.15

597

4527

(3006576) Bicarbonate [Moles/volume] in Blood

348

2.37

11.99

5.3

6.8

26.39

25.07

mmol/l

1.64

311

(3045424) Erythrocytes [Presence] in Urine

629

4682

1.37

11.97

2.3

2.2

0.17

0.19

estimate

0.03

182

1418

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

227

1376

1.66

11.80

1.3

1.2

2.80

3.27

u/ml

0.24

480

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

338

2251

1.52

11.79

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

126

643

1.97

11.58

1.8

2.7

0.81

0.62

e9/l

3.06

119

608

(3010375) cycloSPORINE [Mass/volume] in Blood

462

2.15

11.57

46.3

28.1

143.73

111.71

ug/l

3.74

373

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

218

1317

1.67

11.49

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

474

3390

1.42

11.47

1.3

0.51

0.92

u/ml

0.76

287

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

107

517

2.08

11.44

1.5

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

420

2.20

11.37

1.6

1.7

5.73

11.18

nmol/l

0.41

349

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

174

991

1.77

11.36

1.2

1.1

94.40

98.62

1.40

164

924

(3015736) pH of Urine

4213

38550

1.16

11.35

4.2

3.4

6.22

6.19

1.07

2248

21608

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

134

3.22

11.32

2.0

14.81

17.85

umol/l

1.09

134

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

1361

1.65

11.31

1.3

1.2

3.63

4.10

u/ml

0.32

617

(3006245) CD3-CD19+ cells/cells in Blood

306

2.40

11.01

1.5

2.4

10.05

11.19

0.42

275

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

720

9253

0.76

10.95

1.5

—

(40761536) Microorganisms panel - Urine sediment

890

7051

1.29

10.93

5.0

4.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

500

3649

1.39

10.77

2.1

3.5

35.65

47.78

mg/l

1.82

417

3100

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

160

904

1.78

10.76

2.5

3.1

—

(3037756) Immunofixation for Serum or Plasma

325

2195

1.50

10.64

1.4

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

251

2.52

10.61

3.1

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4376

40283

1.15

10.59

2.9

2.4

72.82

77.74

nmol/l

23.35

3901

36491

(3026250) Tacrolimus [Mass/volume] in Blood

479

2.08

10.58

40.3

38.8

7.63

7.30

ug/l

0.77

432

(3034860) Kappa light chains.free [Mass/volume] in Serum

498

3650

1.38

10.46

2.1

3.5

136.16

69.17

mg/l

0.36

412

3102

(3052592) Norovirus Ag [Presence] in Stool

146

3.02

10.46

1.2

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.62

10.45

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

153

863

1.78

10.36

1.1

1.0

0.46

0.18

u/ml

0.97

287

(36660697) Celiac disease serology panel - Serum

838

6633

1.29

10.36

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

336

2299

1.48

10.32

1.2

—

(3014271) Vancomycin [Susceptibility]

413

2.14

10.20

3.1

2.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

334

2290

1.47

10.16

1.2

—

(3028433) Virus identified in Specimen by Culture

287

2.38

10.14

1.3

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

600

1.93

9.98

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

117

615

1.91

9.93

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

197

1210

1.64

9.81

1.4

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

208

2.60

9.77

1.4

2.4

0.21

0.60

e9/l

0.54

101

(3004451) EKG impression Narrative

107

552

1.95

9.62

1.4

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

212

1335

1.60

9.56

1.2

1.3

235.53

382.58

pmol/l

1.21

167

1126

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

329

2279

1.46

9.52

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1858

16125

1.19

9.52

1.4

1.3

50.62

33.35

iu/ml

3.02

594

4912

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

126

690

1.84

9.45

1.6

18.29

25.51

u/ml

1.41

129

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

120

2138

0.56

9.44

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

123

672

1.84

9.30

1.8

2.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

279

1883

1.50

9.22

1.4

1.3

28.97

33.18

u/l

0.35

237

1621

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

1189

1.62

9.05

1.4

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

367

2.13

9.03

2.7

1.8

510.63

26168.08

u/ml

1.10

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

183

1128

1.63

9.02

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

237

1553

1.54

9.01

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

182

1122

1.63

8.97

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

183

1131

1.63

8.93

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

223

1445

1.56

8.92

1.3

1.4

75.26

66.77

mu/l

0.23

201

1289

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

190

1186

1.61

8.91

1.4

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1273

10742

1.21

8.83

2.6

2.4

203.71

145.61

ug/g

2.05

1022

8644

(3014148) Varicella zoster virus Ab [Titer] in Serum

171

1044

1.65

8.77

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

104

550

1.90

8.73

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

156

933

1.68

8.66

2.2

2.4

12.81

26.50

iu/ml

2.64

124

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

114

625

1.83

8.56

1.2

1.3

681.11

494.88

titre

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

111

604

1.85

8.54

1.3

62.00

61.78

titre

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

369

2667

1.40

8.49

1.3

60.89

35.45

u/ml

0.41

136

(21494815) CD4 cells/Lymphocytes in Specimen

139

811

1.72

8.46

1.8

2.3

40.58

37.50

1.46

130

799

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

415

3062

1.37

8.43

2.8

3.2

1.76

1.61

mg/l

2.14

370

2795

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

154

926

1.67

8.40

1.2

1.1

1.24

1.84

iu/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

438

3262

1.36

8.39

2.1

3.4

7.65

3.09

ratio

0.73

241

1867

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

348

2501

1.41

8.29

1.3

17.26

3.91

u/ml

1.14

237

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

2503

1.40

8.25

1.3

9.43

7.51

u/ml

0.29

368

(3026051) Granulocytes/Leukocytes in Pleural fluid

221

2.41

8.19

1.3

1.4

28.17

24.96

0.30

184

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

294

2056

1.44

8.15

2.4

1.7

0.96

0.85

nmol/l

1.56

233

1740

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

180

1135

1.60

8.14

1.2

1.3

—

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

363

2.07

8.12

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

130

754

1.73

8.10

1.2

257.27

154.88

titre

0.54

125

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8477

87020

0.86

8.06

34.5

16.7

27.28

25.92

mg/l

3.71

7978

72233

(3035320) C reactive protein [Mass/volume] in Body fluid

121

689

1.77

8.05

3.7

2.6

28.48

30.88

mg/l

0.29

102

498

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1011

8420

1.22

7.99

3.2

2.5

0.41

0.44

e6/l

0.28

972

8107

(3037121) Protein [Mass/volume] in Urine

435

3264

1.35

7.95

3.3

3.5

316.44

516.81

mg/l

1.78

228

1569

(3000093) Morphology [Interpretation] in Blood Narrative

154

940

1.65

7.95

1.1

—

(3013512) EKG study

3678

33935

1.13

7.82

4.9

3.7

0.60

0.78

—

(3017509) Phencyclidine [Presence] in Urine

3.78

7.78

2.3

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

259

3698

0.69

7.77

2.0

1.9

39.12

42.47

nmol/l

1.58

248

3587

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

297

2.16

7.73

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

364

2.04

7.69

1.3

1.6

3520.00

3364.71

titre

—

(4035726) Immunohistochemistry procedure

1009

8436

1.22

7.67

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

667

1.75

7.49

1.3

1.2

87.97

82.51

0.95

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

417

1.95

7.43

2.2

2.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

460

1.90

7.38

1.2

1.1

4.12

4.00

iu/ml

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

304

2.11

7.31

1.3

1.5

14.03

12.55

g/l

0.78

223

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

205

1369

1.51

7.23

1.2

1.3

0.16

0.26

nmol/l

1.20

(3013005) Retinol [Moles/volume] in Serum or Plasma

387

1.97

7.21

1.8

1.5

2.02

1.98

umol/l

0.14

363

(3017315) Amylase [Enzymatic activity/volume] in Urine

507

1.84

7.19

1.5

1.2

218.73

483.95

u/l

2.01

465

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

233

1600

1.47

7.16

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

304

2193

1.40

7.14

1.9

33.84

6.48

iu/l

0.50

115

849

(3034988) Calcium [Moles/volume] in Capillary blood

151

2.59

7.08

2.4

1.8

1.16

1.18

mmol/l

0.68

146

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

117

2.83

7.08

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

352

2606

1.36

7.06

1.6

11131.53

13451.63

e6/l

0.58

264

1839

(3000034) Microalbumin [Mass/volume] in Urine

141

871

1.63

7.00

2.9

3.0

85.17

45.18

mg/l

0.45

102

631

(1175426) CD3 cells/Lymphocytes in Blood

119

705

1.70

6.94

1.6

2.1

75.63

72.01

2.74

114

665

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

167

1077

1.56

6.93

1.5

1.3

1.44

1.48

nmol/l

0.16

152

969

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4622

43441

1.12

6.86

3.5

2.9

—

estimate

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

299

2.08

6.84

1.2

1.3

156.48

424.00

ug/l

1.03

137

(3003694) ABO and Rh group [Type] in Blood

2326

25678

0.88

6.82

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

5076

47968

1.11

6.80

4.9

3.8

0.00

estimate

2.33

1168

9863

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

2.76

6.77

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

1083

9224

1.19

6.77

2.4

2.1

0.01

estimate

0.32

220

1858

(3046861) Legionella sp Ag [Presence] in Urine

3.88

6.70

1.3

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

103

593

1.74

6.67

2.3

2.8

39.28

37.03

0.67

320

(3023511) Choriogonadotropin [Units/volume] in Urine

485

1.82

6.60

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

238

2.19

6.56

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.34

6.54

1.0

1.3

61.47

42.96

mg/l

—

(3009261) Glucose [Presence] in Urine by Test strip

5156

48828

1.11

6.52

4.9

3.9

0.04

0.41

estimate

1.27

1072

9357

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

445

1.85

6.47

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

445

1.85

6.47

1.3

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

197

1337

1.48

6.47

1.2

1.3

0.62

3.87

nmol/l

1.18

186

1293

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

547

1.76

6.46

2.6

2.5

672.79

1065.79

u/ml

3.20

541

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

529

4200

1.27

6.46

1.1

56.18

7.35

u/ml

—

(3034426) Prothrombin time (PT)

286

2.07

6.45

1.2

27.71

28.59

0.65

286

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

461

1.83

6.40

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

292

2134

1.38

6.39

1.3

2.78

3.66

u/ml

0.23

139

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

203

2.27

6.34

1.2

1.0

4.98

8.28

u/ml

0.91

132

(3027923) C peptide [Moles/volume] in Serum or Plasma

103

603

1.72

6.31

1.4

1.3

1.32

1.20

nmol/l

0.46

449

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

860

0.44

6.30

1.3

1.4

162.08

176.21

pmol/l

0.21

860

(3032057) Clostridioides difficile [Presence] in Stool

185

2.33

6.29

1.8

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

314

2334

1.36

6.19

4.6

2.9

1.59

1.63

mmol/l

0.26

305

2264

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

161

1058

1.53

6.19

1.2

57.86

65.63

u/l

0.69

141

914

(3029937) Albumin [Presence] in Urine by Test strip

2925

26914

1.12

6.17

5.0

4.0

0.00

estimate

3.79

1073

8958

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

476

1.79

6.09

2.3

2.1

45.40

149.89

ug/min

1.34

127

(3033923) Metanephrine [Moles/time] in 24 hour Urine

157

2.43

6.08

1.2

1.1

0.75

0.71

umol/24h

0.16

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

164

2.38

6.01

11.8

4.79

5.53

mmol/l

1.61

164

(3041918) Cholesterol [Moles/volume] in Pleural fluid

202

2.23

5.98

1.2

1.73

1.58

mmol/l

0.42

131

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

135

2.52

5.92

1.1

1.3

186.34

638.25

ng/l

0.39

100

(3004616) Nuclear Ab [Presence] in Serum

173

1168

1.49

5.87

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

369

2832

1.31

5.87

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

5111

48535

1.11

5.86

4.9

3.8

4.91

4.55

estimate

0.05

1189

10072

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

431

1.82

5.85

1.1

—

(3044889) 12 lead EKG panel

6270

65160

0.90

5.73

5.6

4.2

0.50

4743.83

—

161

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

427

1.81

5.72

3.2

3.3

1.07

1.40

1.04

427

(4094501) Cardiovascular stress test using bicycle ergometer

215

2997

0.71

5.72

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2444

22350

1.12

5.66

4.3

3.7

0.55

0.19

0.54

217

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

765

1.59

5.56

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

171

1167

1.47

5.53

1.2

1.3

0.18

0.21

nmol/l

0.93

130

949

(3017817) Protein [Mass] in Urine collected for unspecified duration

140

917

1.53

5.51

2.1

2.5

1235.89

1021.03

0.39

140

909

(3022145) Colonoscopy Study observation

1293

11370

1.16

5.45

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

166

2.29

5.42

1.2

1.3

0.46

1.61

mmol/l

1.56

121

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

120

764

1.58

5.37

1.0

1.1

302.64

284.81

mg/l

1.90

107

692

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

143

2.38

5.28

1.1

1.3

38.08

287.52

u/l

0.67

110

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

215

2954

0.72

5.27

2.2

1.9

193.64

203.15

pmol/l

0.58

201

2791

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1675

15028

1.14

5.27

1.3

22.52

12.06

u/ml

2.23

560

5789

(4268621) Lupus anticoagulant assay

145

969

1.50

5.22

2.5

2.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

108

2.60

5.20

3.0

3.3

1.46

1.28

mg/l

0.24

(3025941) Bacteria identified in Stool by Culture

554

4541

1.23

5.18

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

434

1.76

5.16

2.2

510.08

2823.27

e6/l

0.69

300

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

263

1.98

5.14

2.0

3.5

1.60

1.88

ratio

0.70

241

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

115

2.53

5.11

1.4

2.3

1.02

1.11

mmol/l

0.07

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

184

1295

1.43

5.10

1.2

39.80

7.03

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

112

712

1.58

5.07

1.2

49.50

40.37

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

895

1.52

5.06

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

178

2.20

5.04

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

135

897

1.51

5.02

1.7

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

205

2.10

4.99

1.2

1.5

1.17

mmol/l

0.18

205

(3019832) Treponema pallidum Ab [Presence] in Serum

545

4478

1.23

4.99

1.6

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

146

989

1.48

4.95

1.2

25.86

42.07

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

111

710

1.57

4.91

1.7

1.8

408.58

337.13

mu/l

0.87

556

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

449

1.72

4.89

1.9

1.5

—

(3014891) Appearance of Pleural fluid

106

2.55

4.86

1.7

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

288

2197

1.32

4.86

1.4

9.75

9.50

u/l

0.12

213

1754

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

127

841

1.52

4.81

1.3

24.27

31.35

u/l

1.68

672

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

589

1.62

4.79

1.2

1.3

42.96

24.97

u/l

1.01

483

(40760888) Immunoglobulin light chains.free panel - Serum

317

2459

1.30

4.74

1.9

3.6

—

1.01

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

220

2956

0.74

4.71

1.8

9.54

4.42

mg/l

3.54

192

2220

(3006922) Hepatitis E virus Ab [Presence] in Serum

114

743

1.54

4.66

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

207

1515

1.37

4.61

1.1

108.11

7872.36

iu/ml

0.54

303

(3013727) Leukocytes other/Leukocytes in Blood

275

1.90

4.56

3.2

3.4

57.44

53.59

0.67

264

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

116

2.42

4.53

1.3

1.4

6.70

323770.46

nmol/l

0.91

101

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

473

3875

1.23

4.49

2.7

3.8

3513.76

1824.29

u/ml

0.41

396

3382

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.86

4.48

3.3

2.2

0.70

0.61

ug/l

0.52

(3050794) Legionella sp Ab [Presence] in Serum

2.65

4.47

1.3

1.0

—

(3007463) Buprenorphine [Presence] in Urine

6.67

4.46

9.0

6.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

208

2.02

4.45

1.4

1.7

0.40

0.38

ug/l

0.07

149

(3002331) Protein [Mass/volume] in Peritoneal fluid

278

1.87

4.43

1.6

1.4

374.10

29.10

g/l

0.48

211

(3044927) Protein electrophoresis panel - Urine

143

989

1.45

4.41

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

252

1915

1.32

4.41

1.3

1.2

43.05

43.74

u/ml

0.02

179

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

611

1.58

4.38

1.2

1.3

112.07

94.82

u/l

0.59

510

(4133840) Spirometry

252

1.91

4.32

1.4

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.00

4.31

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

289

1.84

4.26

1.3

0.34

0.30

g/l

2.62

232

(3020911) Cortisol [Moles/time] in 24 hour Urine

290

1.83

4.22

1.6

1.4

62.66

260.58

nmol/24h

2.08

290

(40768441) Liver Pathology biopsy report

111

738

1.51

4.18

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

372

1.72

4.17

2.2

2.1

7215.24

12154.67

e6/l

0.36

201

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

343

1.75

4.14

1.0

1.1

100.59

98.29

0.29

274

(3041354) Potassium [Moles/volume] in Venous blood

146

1033

1.42

4.02

3.9

2.2

4.10

4.09

mmol/l

0.22

146

1022

(3035285) Chloride [Moles/volume] in Venous blood

146

1033

1.42

4.02

3.9

2.2

104.49

105.66

mmol/l

1.66

146

1022

(3002256) Pathology report gross observation

1145

12821

0.88

4.02

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

123

2.28

4.02

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

111

746

1.49

3.99

1.2

101.78

107.89

pmol/l

0.53

111

746

(3005532) Lymphocytes/Leukocytes in Pleural fluid

355

1.72

3.97

1.5

1.4

53.74

66.42

2.08

296

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

479

1.61

3.91

1.1

1.2

1.07

ratio

0.30

390

(3033705) Calcium.ionized [Moles/volume] in Venous blood

143

1018

1.41

3.83

4.0

2.2

1.19

mmol/l

0.10

143

1007

(40761539) Cells [Type] in Urine sediment by Light microscopy

228

1.89

3.80

1.5

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

570

4837

1.19

3.80

1.7

1.8

—

(4146454) Self-monitoring of blood glucose

153

1105

1.39

3.77

2.6

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

307

2449

1.26

3.76

2.4

151.76

117.49

ug/min

0.48

183

1488

(3034274) Bile acid [Moles/volume] in Serum --fasting

510

1.57

3.69

1.5

1.6

10.98

12.24

umol/l

0.12

360

(3049717) Cytology report of Urine Cyto stain

504

4246

1.20

3.66

2.8

—

(3036005) Urine sediment comments by Light microscopy Narrative

7.78

3.55

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

407

1.63

3.51

3.4

3.2

26.50

24.41

mu/l

0.22

385

(43055442) Apixaban [Mass/volume] in Serum or Plasma

158

2.03

3.49

1.9

1.6

91.78

113.60

ug/l

0.65

127

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

639

1.49

3.46

1.1

—

0.62

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

394

1.63

3.43

2.7

0.61

mmol/l

0.01

394

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

266

1.77

3.42

1.4

1.6

9.35

9.49

ug/l

0.06

266

(3038515) Glucose [Moles/volume] in Venous blood

247

1944

1.28

3.42

5.0

3.1

7.55

7.67

mmol/l

0.29

240

1888

(3021788) Differential panel - Synovial fluid

243

1909

1.28

3.41

1.6

1.5

—

1.00

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.34

3.40

1.2

12.32

9.71

mg/l

0.34

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

482

1.56

3.37

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

157

1163

1.36

3.36

2.3

2.1

4978.72

4698.63

u/l

0.04

439

(3021387) Prolactin [Units/volume] in Serum or Plasma

264

2102

1.26

3.33

1.6

1.7

366.40

283.15

mu/l

2.21

236

1945

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

614

5306

1.17

3.33

1.8

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

390

3240

1.21

3.32

1.7

1.6

24.36

20.96

u/ml

0.20

748

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

429

1.59

3.32

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.92

3.29

1.1

1.2

5297.71

3036.35

ng/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

446

1.57

3.28

1.4

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

124

891

1.40

3.21

1.2

1.1

—

80.31

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

213

1.83

3.20

1.6

1.4

0.30

0.24

mmol/l

—

(40768443) Skin Pathology biopsy report

510

4357

1.18

3.20

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

146

1081

1.36

3.16

1.3

85.19

60.36

u/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1267

11527

1.11

3.13

5.2

32.03

31.99

0.04

891

7703

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.25

3.12

1.3

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

133

974

1.37

3.09

1.3

1.4

129393.39

114842.13

e6/l

0.09

652

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

173

1.91

3.08

1.3

1.2

0.79

98.44

mg/l

1.25

127

(3044007) Cell count panel - Peritoneal fluid

367

1.61

3.07

2.5

2.0

—

(3036180) Methadone [Presence] in Urine

7.50

3.05

14.3

2.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

100

2.20

2.98

1.4

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

141

1049

1.35

2.98

1.4

1.2

—

(3017704) Immunofixation for Urine

546

1.49

2.97

1.3

1.5

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

301

1.66

2.97

1.6

1.4

6.54

2.36

1.39

258

(3020491) Glucose [Moles/volume] in Blood

621

1.45

2.94

2.0

1.7

7.59

6.92

mmol/l

0.90

423

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

121

2.07

2.91

1.2

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

121

2.07

2.91

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

121

2.07

2.91

1.2

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

445

0.49

2.89

1.7

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

550

1.48

2.88

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

642

1.44

2.85

1.1

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

143

1.96

2.84

1.5

9.71

10.82

0.09

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

116

2.07

2.82

2.5

3.9

36.17

39.62

umol/l

0.35

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.64

2.79

1.8

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

671

1.42

2.77

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

101

722

1.40

2.75

1.4

1.3

2.25

2.18

mmol/l

0.17

679

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

339

1.60

2.75

2.7

3.0

28.49

28.33

umol/l

0.04

252

(3029634) Reagin Ab [Titer] in Serum by VDRL

156

1194

1.31

2.74

2.4

12.33

3.52

titre

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

656

1.42

2.73

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

292

3519

0.82

2.70

2.4

4.0

45.96

65.99

u/ml

1.09

277

3393

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

125

2.00

2.69

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

584

1.44

2.68

2.1

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

417

3564

1.18

2.66

1.3

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

374

1.55

2.65

1.1

84.00

11.67

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

351

2959

1.19

2.63

1.6

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.25

2.60

1.7

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

282

1.63

2.59

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

282

1.63

2.59

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

282

1.63

2.59

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

282

1.63

2.59

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

689

1.40

2.58

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

689

1.40

2.58

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

706

1.39

2.58

1.1

1.2

—

(4024509) Urine culture

485

4209

1.16

2.56

2.2

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

200

1.75

2.55

1.3

1.2

515.00

293.25

pmol/l

0.45

157

(3019420) Tryptase [Mass/volume] in Serum or Plasma

475

1.48

2.54

1.6

10.04

10.87

ug/l

0.11

433

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.23

2.51

1.0

1.3

—

mmol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

115

2.00

2.50

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

434

0.53

2.49

1.6

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

535

0.58

2.46

5.0

7.3

73.86

150.45

ug/l

0.38

354

(3023323) Follitropin [Units/volume] in Serum or Plasma

303

2540

1.20

2.44

1.4

28.81

32.94

iu/l

1.50

246

2150

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

563

1.42

2.42

1.2

1.1

22.60

28.77

u/l

0.66

499

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

280

1.61

2.41

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

145

1.86

2.41

1.9

2.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

724

1.37

2.40

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

235

1.66

2.37

1.1

1.2

93.90

85.67

0.71

126

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.61

2.35

1.3

1.7

—

(3000012) Reticulocyte production index

190

1526

1.25

2.34

1.7

2.3

0.87

0.90

0.32

132

1052

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

514

0.58

2.34

1.7

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

619

1.39

2.31

1.6

1.5

4.45

7.21

u/l

2.14

490

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

108

807

1.34

2.30

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

570

1.41

2.28

1.2

1.1

87.93

88.92

u/l

0.04

508

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

373

1.50

2.26

1.2

2.1

197.27

166.62

1.59

354

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

488

1.44

2.25

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

488

1.44

2.25

1.3

1.5

—

(40768804) Tissue Pathology biopsy report

3510

36507

0.94

2.23

2.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

519

0.60

2.23

1.7

1.5

0.91

0.97

ratio

0.61

326

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

519

0.60

2.23

1.7

1.5

1.36

1.22

ratio

0.24

327

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

232

1.64

2.22

1.1

1.3

94.32

86.13

0.47

128

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

518

0.60

2.21

1.7

1.5

0.97

1.13

ratio

0.55

325

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.34

2.21

1.4

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

287

1.57

2.21

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.19

2.20

1.3

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

172

1.75

2.20

1.1

0.32

1.40

u/ml

1.07

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

264

1.59

2.19

1.3

1.5

14.32

15.71

pmol/l

0.90

220

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

165

1.76

2.18

1.8

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

180

0.39

2.14

1.1

124.09

70.96

u/ml

—

174

(3020876) Protein [Mass/time] in 24 hour Urine

171

1373

1.25

2.14

2.1

2.5

1.60

1.25

g/24h

0.85

102

817

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

569

1.39

2.14

1.4

1.5

6.00

5.96

u/l

0.02

501

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

278

2346

1.19

2.13

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

130

1.85

2.11

1.0

1.2

60.38

64.82

ug/l

0.57

130

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

145

1.80

2.09

2.0

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

229

1.62

2.07

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

2.04

1.1

0.07

0.02

u/ml

0.98

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

169

1.72

2.03

1.1

1.3

77.80

75.48

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

109

835

1.31

2.00

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.81

2.00

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.81

2.00

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

141

1119

1.26

1.98

1.1

2.79

3.01

—

156

(40768793) Breast Pathology biopsy report

133

1673

0.79

1.94

1.4

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.75

1.93

1.8

1.4

2.32

2.37

g/l

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.45

1.92

1.4

36.21

32.15

nmol/l

0.08

(21494890) Protein electrophoresis panel - 24 hour Urine

138

1097

1.26

1.92

1.6

2.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

882

8100

1.10

1.89

3.6

2.7

65.52

65.65

ml/min/173m2

0.03

410

3344

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

316

1.49

1.87

4.5

8.0

6.13

5.95

kpa

0.49

279

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

114

1.84

1.86

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

449

1.41

1.86

4.0

5.5

65.78

1472.16

mg/l

1.09

328

(3016135) IgD [Mass/volume] in Serum

4.17

1.82

1.8

1.0

29.98

36.14

mg/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

468

1.39

1.81

1.3

1.2

0.52

0.70

ratio

0.68

271

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

222

1.58

1.81

1.3

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.06

1.80

1.3

1.5

—

(3033086) Enterovirus Ab [Titer] in Serum

3.05

1.79

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

168

1.67

1.79

1.1

1.3

111.40

78.93

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

152

1233

1.24

1.79

1.4

1.6

58.59

59.07

0.05

104

772

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

116

1.81

1.78

1.1

20.42

21.33

u/l

0.09

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

232

1.55

1.75

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

232

1.55

1.75

1.3

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

1.90

1.75

1.2

1.3

—

110.27

—

(3033099) Centromere Ab [Titer] in Serum

209

1.58

1.73

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

439

1.39

1.72

1.3

1.2

34.50

62.34

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

272

2340

1.17

1.72

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

258

1.51

1.70

2.2

2.3

463.44

166.96

ug/l

0.28

258

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

277

2394

1.16

1.66

1.3

582.07

584.03

mg/l

0.02

260

2288

(3051387) C reactive protein [Mass/volume] in Capillary blood

216

1830

1.18

1.66

5.6

3.4

30.20

29.13

mg/l

0.17

161

1256

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.10

1.65

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

140

1138

1.23

1.65

1.3

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

805

0.73

1.63

1.0

40.11

41.52

ng/l

0.10

571

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.38

1.61

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

428

1.38

1.61

1.2

1.3

168.19

176.18

mmol/24h

0.25

428

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

802

0.73

1.59

1.0

851.47

731.71

ng/l

1.20

558

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.50

1.59

1.0

0.03

0.33

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

246

2115

1.17

1.59

1.2

1.1

2.85

3.49

0.49

242

(3024869) Neuronal Ab [Presence] in Serum

198

1.57

1.59

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

279

1.47

1.58

4.5

8.0

5.79

5.43

kpa

0.55

279

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

628

1.31

1.58

1.2

1.1

384.43

300.02

mg/l

0.42

552

(3014051) Protein [Presence] in Urine by Test strip

2652

25496

1.05

1.57

3.7

2.9

0.20

0.05

0.84

583

(3016750) Collection duration of Urine

568

1.32

1.56

2.2

2.3

495.50

492.48

min

0.08

426

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

799

0.74

1.56

1.0

318.02

326.73

ng/l

0.07

576

(3022621) pH of Urine by Test strip

778

7175

1.09

1.56

3.6

2.5

6.09

6.01

1.60

551

4902

(3019150) Specific gravity of Urine by Refractometry

2219

21234

1.06

1.56

5.2

4.1

1.02

1.16

kg/l

0.81

1588

14297

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

215

1.54

1.56

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.85

1.55

1.2

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.27

1.55

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

683

1.29

1.54

1.5

2.1

17.30

17.09

nmol/l

0.07

647

(3034092) Cytoplasmic Ig cells/cells in Blood

100

1.80

1.52

15.9

8.5

0.35

0.19

1.59

100

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.86

1.50

1.5

1.0

3.00

2.33

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

245

2118

1.16

1.50

1.3

4.01

3.83

mmol/l

1.35

225

2014

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.86

1.50

1.4

6.84

18.56

pmol/l

—

(3024263) Appearance of Synovial fluid

503

1.33

1.49

1.8

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

154

1.62

1.49

1.9

1.8

50.58

48.31

pmol/l

0.06

131

(1617658) Protocol used for examination of sentinel lymph nodes

537

0.69

1.49

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

732

1.27

1.48

1.2

10.13

9.31

mmol/l

0.96

682

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.43

1.47

1.2

1.4

384.22

557.90

nmol/l

—

(44806420) Estimation of glomerular filtration rate

937

0.77

1.46

2.5

2.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

276

1.45

1.46

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

195

1.54

1.45

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.92

1.43

1.3

1.1

4.71

12.58

u/l

1.26

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

922

0.77

1.43

1.6

1087.28

1009.62

mu/l

0.17

761

(3006462) Nitrate [Presence] in Urine

404

1.36

1.42

3.3

3.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

245

1.47

1.41

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

197

1.52

1.39

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

221

1909

1.16

1.39

1.2

1.3

150.64

215.28

miu/ml

1.43

779

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.89

1.38

1.1

53.71

10.60

iu/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

256

1.45

1.35

1.4

1.3

32.16

38.97

0.64

167

(3018133) Calcium [Moles/volume] in Urine

160

1.56

1.31

2.0

1.6

2.95

2.68

mmol/l

0.27

141

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

589

6399

0.92

1.31

2.4

24.46

22.03

au/ml

0.25

636

(4034850) Laboratory test

253

2877

0.88

1.30

18.7

10.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.09

1.30

4.0

3.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

309

1.39

1.29

1.4

1.3

3.17

3.91

umol/l

0.77

267

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

257

0.58

1.29

1.0

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.35

1.29

7.9

5.9

398.75

427.94

umol/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.08

1.27

1.0

0.03

1.10

u/ml

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.94

1.27

15.0

10.3

109.83

356.58

e6/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.05

1.26

1.3

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

258

2273

1.14

1.26

3.0

3.8

187.22

862.04

u/ml

3.35

226

2085

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

653

1.26

1.23

1.3

1.1

67.06

44.31

mg/l

0.39

555

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.04

1.21

2.8

13.0

108.80

106.76

g/l

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.72

1.21

1.2

1.3

95.16

114.11

ug/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

205

1.46

1.19

2.1

2.3

7.49

7.92

mmol/l

0.22

120

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

480

1.29

1.17

1.4

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

256

1.41

1.17

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

237

2090

1.14

1.16

1.5

1.4

53.69

30.37

e6/l

0.23

181

1531

(3050129) First trimester maternal screen panel - Serum or Plasma

611

0.75

1.14

1.8

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

404

1.31

1.13

2.9

2.3

50.53

54.01

umol/l

0.34

349

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

240

2123

1.13

1.5

1.4

1466.79

1563.25

e6/l

0.06

196

1659

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

367

0.68

1.13

1.4

1.2

11.68

10.97

mm/h

0.09

367

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

250

1.40

1.12

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.96

1.11

1.3

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

663

1.24

1.11

1.4

16.08

13.39

umol/l

1.65

623

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.38

1.09

1.0

2.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.87

1.07

2.8

3.3

—

(1002224) Polysomnography panel

393

4300

0.91

1.07

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

202

1.44

1.07

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

738

0.78

1.06

3.3

6.0

190.73

57.79

u/ml

0.43

244

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.65

1.06

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

1.65

1.06

2.6

2.1

56.14

58.13

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

444

1.29

1.06

1.1

1453.14

1539.85

miu/ml

0.29

444

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

531

4916

1.08

1.06

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1020

9664

1.06

1.05

1.6

1.5

—

6.09

—

(3011897) Casein IgE Ab [Units/volume] in Serum

105

1.62

1.05

1.3

1.2

0.30

5.04

u/ml

0.50

105

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.12

1.05

1.1

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

227

2014

1.13

1.04

1.7

2.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

678

1.23

1.04

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.2

1.0

—

(4211845) Urine protein measurement

446

1.28

1.03

3.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

107

0.47

1.00

8.8

6.1

5.20

8.59

—

107

(40761995) Spermatozoa Progressive [#/volume] in Semen

108

0.46

1.00

4.4

3.1

45.40

43.24

—

108

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

160

1836

0.87

1.00

1.4

1.5

—

(44806071) Cardiolipin IgM antibody measurement

123

1.55

0.99

1.1

—

(40768446) Kidney Pathology biopsy report

424

1.28

0.96

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

229

2047

1.12

0.95

1.1

14.97

8.67

eliau/ml

0.21

251

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

101

1.59

0.93

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.73

0.92

1.2

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.14

0.91

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.14

0.91

1.0

1.1

25.55

34.44

mg/24h

—

(3023410) Appearance of Cerebral spinal fluid

107

910

1.18

0.91

1.8

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

279

1.33

0.89

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

485

0.76

0.89

1.2

1.1

21.56

20.78

u/ml

—

194

(37021550) Renin [Units/volume] in Plasma --upright

185

1.41

0.89

1.3

77.21

65.95

mu/l

0.13

139

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

265

2408

1.10

0.84

1.8

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

552

5886

0.93

0.84

1.3

45.65

55.19

au/ml

0.51

413

(3013762) Body weight Measured

1.94

0.84

1.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

579

1.21

0.82

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

430

3998

1.08

0.82

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.67

0.78

2.8

3.3

—

(3045142) Bone marrow Pathology biopsy report

108

1245

0.87

0.78

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

484

1.22

0.77

1.8

1.9

2.40

3.07

u/field

0.27

341

(3041096) Erythrocytes [Presence] in Urine by Automated

2604

25407

1.03

0.76

4.6

3.3

0.01

0.23

estimate

2.35

940

7724

(3025130) Human papilloma virus identified in Specimen

843

1.16

0.76

1.9

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

409

3811

1.08

0.76

1.1

288.75

215.14

titre

0.28

117

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

200

1.35

0.76

1.0

1.1

828.57

917.39

titre

—

(3004775) Volume in Urine collected for unspecified duration

817

1.16

0.74

2.4

647.37

679.34

0.28

553

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.67

0.74

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.84

0.73

1.3

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

1.34

0.28

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

469

1.22

0.73

1.2

1.1

1.14

1.21

u/l

0.23

205

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.62

0.71

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

264

0.72

0.70

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.92

0.70

1.2

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

318

1.26

0.70

1.3

40.34

40.00

g/l

0.06

159

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

328

1.25

0.68

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

127

1.42

0.67

1.6

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

119

0.59

0.67

1.3

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

120

0.58

0.67

1.0

—

(3025577) Chromium [Mass/volume] in Blood

638

0.83

0.67

2.2

3.37

2.30

ug/l

0.36

523

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.63

0.66

1.1

185.00

263.89

nmol/l

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.49

0.66

1.0

1.1

0.18

1.27

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.61

0.65

1.5

1.4

505.90

323.10

umol/24h

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

587

1.18

0.64

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

597

1.17

0.64

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

162

1791

0.90

0.63

1.8

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

457

0.81

0.61

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

289

1.25

0.60

1.1

1.3

108.10

133.22

nmol/l

0.50

214

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.71

0.57

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.71

0.57

1.3

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

193

1.30

0.57

1.2

1.1

—

22.13

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

161

0.68

0.57

6.1

6.5

8.55

8.42

mmol/l

0.05

161

(3027874) Urate [Moles/volume] in Urine

1.67

0.56

1.2

1.0

1.67

1.98

mmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.58

0.56

1.2

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.51

0.56

2.4

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

531

1.17

0.56

9.3

6.5

103.60

519.34

u/ml

0.66

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.56

3.0

5.5

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

1.45

0.56

1.1

1.6

5.63

13.15

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.45

0.56

11.1

9.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

266

1.24

0.55

1.2

—

(21494434) Karyotype in Bone marrow

102

908

1.12

0.54

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

394

1.19

0.54

1.2

1.1

61.69

348.29

ng/l

2.07

109

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

580

1.16

0.53

1.0

1.1

8.63

9.54

nmol/l

0.06

121

(3003740) Influenza virus B Ag [Presence] in Specimen

121

1342

0.90

0.53

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1089

0.89

0.53

1.4

1.2

7.45

7.57

mmol/l

0.15

952

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.52

0.52

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

161

1.30

0.51

1.0

1.1

—

(3008898) HLA-B27 [Presence]

242

2595

0.93

0.51

1.1

—

(40762814) Titanium [Mass/volume] in Blood

170

1.29

0.51

2.8

2.6

3.70

3.82

ug/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

252

1.23

0.49

1.5

1.2

17.78

13.57

pmol/l

0.29

(3009015) Lactate [Moles/volume] in Synovial fluid

119

1.35

0.48

1.1

1.3

5.29

6.61

mmol/l

—

(3020650) Glucose [Presence] in Urine

308

1.20

0.47

1.5

1.6

0.00

0.05

estimate

1.74

308

(3002523) Influenza virus A Ag [Presence] in Specimen

122

1341

0.91

0.47

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

102

919

1.11

0.47

1.4

1.5

26.21

28.70

0.29

566

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.46

0.46

1.1

1.5

3.39

4.44

nmol/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

420

1.17

0.46

1.4

1.1

—

(3006270) Folate [Moles/volume] in Blood

707

0.88

0.45

1.2

369.78

365.80

nmol/l

0.05

590

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.60

0.45

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

187

0.75

0.45

1.0

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

865

0.89

0.45

1.3

1.4

0.21

0.25

nmol/l

0.66

607

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

347

1.18

0.45

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

422

1.16

0.44

1.6

2.0

38.88

40.34

g/l

0.97

422

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

320

1.19

0.44

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.37

0.44

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.37

0.44

1.3

1.4

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

130

1.31

0.43

1.2

1.4

42.40

56.22

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.37

0.43

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.41

0.43

1.1

1.2

2.02

1.79

umol/24h

0.38

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.41

0.43

3.5

6.1

—

(3016228) CD19 cells/cells in Blood

396

1.16

0.42

1.7

2.0

7.33

8.06

0.25

381

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.42

1.3

1.2

—

(4212803) Bone marrow aspirate examination

0.64

0.42

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

221

1.22

0.42

4.5

7.0

10.61

10.63

0.01

221

(3020393) Adenovirus Ag [Presence] in Stool

1.38

0.42

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.64

0.42

1.0

1.42

8.29

u/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

397

1.16

0.41

1.7

2.0

28.78

32.22

0.98

397

(3035060) Mercury [Moles/volume] in Blood

0.00

0.40

0.0

2.1

—

13.62

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

324

1.17

0.40

1.7

2.0

2.36

1.65

ratio

1.23

308

(3005082) Progesterone [Moles/volume] in Serum or Plasma

115

1.30

0.38

1.3

1.4

28.22

31.02

nmol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

159

0.75

0.38

1.5

1.6

4.30

2.32

ug/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

323

0.84

0.38

1.2

1.7

3.81

4.60

ug/l

0.22

240

(40768795) Lymph node Pathology biopsy report

1009

0.91

0.37

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.43

0.35

1.0

—

(3012565) Volume of 24 hour Urine

498

1.13

0.35

2.0

2.3

1941.38

1936.30

0.01

437

(3034891) Synovial lining cells/cells in Synovial fluid

489

1.13

0.35

1.3

1.5

3.00

3.51

—

108

(1761482) Bacteria [#/volume] in Urine by Culture

211

2232

0.94

0.35

5.4

3.9

—

(40763590) HLA-DQ beta [Type]

1.36

0.34

1.0

—

(3000330) Specific gravity of Urine by Test strip

494

4769

1.04

0.34

4.1

3.3

1.02

ratio

0.47

441

4336

(40760409) HLA-A [Type] by High resolution

1.33

0.33

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.33

0.33

1.0

—

(40760410) HLA-B [Type] by High resolution

1.33

0.33

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.30

0.33

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

118

1.27

0.33

1.5

1.6

—

(3013862) HLA-DP [Type]

1.30

0.33

1.0

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.30

0.33

1.2

1.5

2.00

1.04

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.70

0.33

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.67

0.32

1.2

1.0

—

(3001729) Color of Synovial fluid

1.35

0.32

1.2

1.5

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

286

1.15

0.31

1.3

59.80

54.91

0.30

241

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

727

1.09

0.28

2.1

1.9

1.69

1.39

u/field

0.24

403

(3043410) Blood group antigens tested for on Red Blood Cells

251

1.16

0.28

1.8

1.9

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

1.32

0.28

3.3

2.1

14.60

16.39

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

126

1341

0.94

0.28

1.3

1.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

1.27

0.27

1.1

1.6

52.13

31.86

—

(4281824) Cell count and differential, peritoneal fluid

916

0.93

0.26

1.2

—

(40765096) Chromosome analysis panel by Banding

331

0.88

0.26

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

132

1.21

0.25

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

550

1.09

0.25

1.1

8.06

9.89

iu/ml

0.25

147

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.71

0.24

1.2

6.15

6.30

mmol/l

—

(40758292) HTLV I+II Ab panel - Serum

190

0.84

0.23

1.1

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

399

1.10

0.23

1.7

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.9

—

114.00

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.40

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

111

0.81

0.20

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

404

1.09

0.19

1.1

1.0

0.95

1.40

u/ml

0.24

121

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.19

0.19

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

137

1.17

0.18

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

204

1.13

0.18

1.1

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.17

0.17

1.6

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.76

0.17

3.0

4.1

—

0.00

estimate

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.74

0.17

1.8

5.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

130

0.85

0.16

2.3

3.2

43.50

141.73

ng/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

104

1084

0.96

0.14

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

150

1.13

0.14

4.4

6.1

32.18

52.62

ug/min

1.35

121

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

388

0.93

0.14

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

305

1.08

0.13

1.3

1.2

50.71

22.58

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

106

0.85

0.13

1.4

1.9

—

(3027035) Albumin [Mass/time] in 24 hour Urine

107

0.84

0.13

1.3

—

479.41

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6669

66521

1.01

0.13

4.7

4.2

15.05

14.81

pmol/l

10.88

6059

60948

(3013139) Helicobacter pylori Ag [Presence] in Stool

597

6051

0.99

0.12

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

176

0.91

0.09

1.3

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.78

0.08

2.4

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1123

11158

1.01

0.08

9.8

7.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.86

0.07

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.12

0.07

1.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.83

0.07

1.8

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.07

0.07

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.05

0.07

1.0

1.1

60.00

92.63

titre

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

106

1035

1.02

0.07

1.1

3.42

3.81

eliau/ml

0.19

454

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

152

0.92

0.06

1.1

44.92

39.60

iu/ml

0.09

152

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

188

1.06

0.05

2.2

1.7

—

89.24

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.05

1.1

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

100

1.10

0.05

3.2

2.7

654.18

302.48

umol/l

0.42

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

327

1.04

0.05

1.6

1.5

65.19

59.12

ug/l

0.37

327

(3047189) Immunofixation for 24 hour Urine

524

0.97

0.04

1.2

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

271

1.03

0.02

1.6

1.7

0.69

0.95

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3629

36256

1.00

0.02

5.0

3.8

0.01

0.25

estimate

1.88

955

8112

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

128

1268

1.01

0.02

1.1

16.12

18.33

au/ml

0.10

280

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

103

1.07

0.02

2.5

2.7

0.73

0.40

u/field

0.41

103

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

233

1.03

0.01

3.6

6.9

64.67

69.37

0.25

185

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

512

5131

1.00

0.01

1.2

123.13

131.86

u/ml

0.20

151

1902

(3010838) Calcium [Moles/time] in 24 hour Urine

166

1653

1.00

0.00

1.9

4.13

5.11

mmol/24h

3.37

143

1473

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.04

0.00

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

443

0.99

0.00

1.7

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

726

1.01

0.00

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

275

1.02

0.00

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

345

1.01

0.00

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

108

1.02

0.00

1.0

2.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

338

1.01

0.00

1.1

1.0

0.28

1.47

u/ml

0.57

(3025018) Bordetella pertussis Ab [Titer] in Serum

518

1.00

0.00

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

381

1.00

0.00

1.1

1.0

5.51

1.58

u/ml

0.35

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

1.01

0.00

1.1

1.3

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.52

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.33

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.07

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.95

-0.00

2.1

2.7

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.8

—

10.44

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.90

-0.00

1.7

2.0

216.00

200.71

ng/l

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

59.13

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.48

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.96

-0.00

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.01

-0.00

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.92

-0.00

1.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

273.40

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

49.12

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.00

-0.00

1.8

1.4

0.15

0.17

umol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint COPD_EARLY and mortality.

Females

Parameter	HR [95% CI]	p-value
COPD_EARLY	5.788 [5.33, 6.28]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 5790 out of 19608 females with COPD_EARLY died.

Males

Parameter	HR [95% CI]	p-value
COPD_EARLY	4.076 [3.78, 4.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 14125 out of 35925 males with COPD_EARLY died.

Mortality risk

Mortality risk for people of age

years, who have COPD_EARLY.

N-year risk	Females	Males
1	0.467%	0.687%
5	2.872%	4.076%
10	6.558%	10.345%
15	12.484%	19.555%
20	21.139%	31.398%

Relationships between endpoints

↥

Index endpoint: COPD_EARLY – Early onset COPD

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Early onset COPD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints